Other sleep disorders

G6_SLEEPDISOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G47 Hospital discharge: ICD-9 — 3478\|3074 Hospital discharge: excluded ICD-10 — G47.3, G47.4 Cause of death: ICD-10 — G47 Cause of death: ICD-9 — 3478\|3074 Cause of death: excluded ICD-10 — G47.3, G47.4 2 out of 7 registries used, show all original rules.	5970
4. Check minimum number of events None	5970
5. Include endpoints None	5970
6. Filter based on genotype QC (FinnGen only)	5289

Control definitions (FinnGen only)

Control exclude: G6_EPIPAROX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G40-G47
Name in latin: Perturbationes somni (organicae)

NAME	G6_SLEEPDISOTH
CONTROL_EXCLUDE	G6_EPIPAROX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G47
HD_ICD_9	3478\|3074
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	G47[3-4]
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G47
COD_ICD_9	3478\|3074
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	G47[3-4]
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other sleep disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37822	14792	22784
Only index persons	33930	13696	20234
Unadjusted period prevalence (%)
Whole population	0.55	0.42	0.64
Only index persons	0.66	0.50	0.77
Median age at first event (years)
Whole population	48.61	48.62	48.49
Only index persons	47.84	48.07	47.68

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5289	2693	2596
Unadjusted period prevalence (%)	1.07	0.96	1.19
Median age at first event (years)	50.02	48.30	51.79

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5497: Matched controls
54969

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G40.9

ICD-10 Finland

Epilepsy, unspecified

88.9

312.3

164

N06AX11

ATC

mirtazapine; oral

3.6

307.7

2659

11323

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

28.4

307.7

1091

475

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

25.3

307.7

329

138

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

2251.5

307.7

437

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.9

307.7

959

1431

XG466

NOMESCO Finland

Sleep oxymetry

24.4

307.7

393

173

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

382.6

307.7

391

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

165.8

307.7

161

WX722

NOMESCO Finland

PEEP

18.1

307.7

489

295

G47.9

ICD-10 Finland

Sleep disorder, unspecified

143.5

307.7

2680

362

N05AH04

ATC

quetiapine; oral

3.9

307.7

1615

5310

P06

ICPC

Sleep disturbance

4.6

307.7

1150

2963

WX780

NOMESCO Finland

Remote monitoring CPAP

3777.7

307.7

364

G47.3

ICD-10 Finland

Sleep apnoea

53.9

307.7

2861

1086

WX723

NOMESCO Finland

CPAP therapy

350.1

307.7

360

R5140

NOMESCO Finland

Monitoring the use of the aid

19.9

307.7

1010

615

G44.2

ICD-10 Finland

Tension-type headache

4.8

307.7

875

2086

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

307.7

583

R06.5

ICD-10 Finland

Mouth breathing

8.7

307.7

986

1340

G47.8

ICD-10 Finland

Other sleep disorders

20.8

307.7

610

328

N06AX16

ATC

venlafaxine; oral

4.0

307.7

1210

3610

F51.0

ICD-10 Finland

Nonorganic insomnia

3.3

293.5

1439

5372

N06AX21

ATC

duloxetine; oral

4.0

290.9

949

2714

G43.9

ICD-10 Finland

Migraine, unspecified

8.2

285.2

394

515

N06AB04

ATC

citalopram; systemic

3.2

281.5

1460

5619

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

7.3

277.8

426

627

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.6

271.5

1080

3524

N03AE01

ATC

clonazepam; systemic

5.5

260.9

538

1062

N05CF01

ATC

zopiclone; oral

2.7

256.4

2096

10225

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

255.2

243

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.5

253.6

681

1677

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

7.3

250.9

381

554

R53

ICD-10 Finland

Malaise and fatigue

2.8

249.3

1762

7966

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

248.8

237

N03AG01

ATC

valproic acid; systemic, rectal

6.1

245.3

452

802

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.9

243.9

826

2409

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

7.6

238.7

348

483

Z01.8

ICD-10 Finland

Other specified special examinations

2.8

236.9

1562

6785

R51.80

ICD-10 Finland

Headache

3.3

233.9

1040

3615

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

3.7

231.0

844

2587

N05BA04

ATC

oxazepam; oral

2.7

229.5

1739

8090

N03AX16

ATC

[U] pregabalin

2.8

224.9

1483

6420

3478X

ICD-9 Finland

Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]

+∞

222.4

212

E66.01

ICD-10 Finland

Obesity due to excess calories

4.0

221.2

691

1898

XA420

NOMESCO Finland

Extensive sleep examination

45.9

220.9

130

N04BC05

ATC

pramipexole; oral

4.3

219.0

614

1557

N03AX09

ATC

lamotrigine; oral

5.6

215.2

429

818

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.4

213.2

587

1467

N06BA07

ATC

modafinil; oral

45.3

210.1

124

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.8

206.8

697

2016

N06AX12

ATC

bupropion; oral

4.0

206.2

636

1728

N06AB03

ATC

fluoxetine; oral

3.3

205.9

899

3074

N06AB10

ATC

escitalopram; oral

2.7

205.0

1415

6233

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.2

200.4

436

898

G43.3

ICD-10 Finland

Complicated migraine

35.2

197.0

124

R06.0

ICD-10 Finland

Dyspnoea

2.5

192.7

1654

8062

N03AF02

ATC

oxcarbazepine; oral

12.1

192.2

195

167

N03AX12

ATC

[U] gabapentin; oral

3.0

191.6

1035

3993

N03AX11

ATC

topiramate; oral

12.6

190.6

188

154

N06AX26

ATC

vortioxetine; oral

3.7

185.9

640

1873

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.7

184.1

657

1969

N06AX03

ATC

mianserin; oral

4.9

182.9

420

905

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.5

182.6

481

1158

N06AB06

ATC

sertraline; oral

3.1

179.6

852

3046

E66.8

ICD-10 Finland

Other obesity

4.8

175.7

417

923

N05BA01

ATC

diazepam; systemic, rectal

3.1

174.3

856

3119

N05CF02

ATC

zolpidem; oral

2.7

172.9

1162

5004

3007

Kela drug reimbursment

Erenumab and fremanezumab

39.6

172.2

105

N02AX02

ATC

tramadol; systemic, rectal

2.2

172.1

2488

14995

R03AC02

ATC

salbutamol; inhalant

2.2

171.4

3175

21084

N06AA09

ATC

amitriptyline; systemic

3.7

171.1

606

1804

E66.00

ICD-10 Finland

Metabolic syndrome

4.6

166.5

420

976

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.5

164.4

617

1906

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

161.2

1180

5281

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.7

160.5

393

891

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

3.0

158.3

785

2867

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

157.2

807

3005

N06AA12

ATC

doxepin; systemic

4.5

151.9

392

926

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

151.1

1687

9061

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

6.1

149.2

268

461

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

148.9

1625

8639

N05CD07

ATC

temazepam; oral

3.0

148.6

726

2624

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

148.3

2180

13024

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.2

146.6

652

2231

R42

ICD-10 Finland

Dizziness and giddiness

2.4

145.6

1303

6361

ENC30

NOMESCO Finland

Plastic operation of pharynx

12.5

144.0

142

116

M54.5

ICD-10 Finland

Low back pain

2.1

142.7

2160

12999

M79.7

ICD-10 Finland

Fibromyalgia

5.7

141.2

272

500

A02BC02

ATC

pantoprazole; systemic

2.1

137.9

3752

27778

C07AA05

ATC

propranolol; systemic

2.4

137.3

1224

5947

R01AD09

ATC

mometasone; nasal

2.0

136.2

2566

16638

AA1AD

NOMESCO Finland

CT of head and brain

2.2

135.5

1430

7456

A02BC05

ATC

esomeprazole; systemic

2.0

135.3

2248

13930

M79.1

ICD-10 Finland

Myalgia

2.5

134.3

983

4365

P03

ICPC

Feeling depressed

2.8

132.3

734

2836

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

132.2

1473

7838

N05AA02

ATC

levomepromazine; systemic

4.4

132.0

341

805

N06AX05

ATC

trazodone; oral

5.9

132.0

241

421

M79.6

ICD-10 Finland

Pain in limb

2.0

130.5

2498

16213

N05AH03

ATC

olanzapine; systemic

3.4

128.5

503

1588

G45.3

ICD-10 Finland

Amaurosis fugax

50.0

128.0

P29

ICPC

Psychological sympt/compl other

3.1

127.3

599

2111

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

126.5

432

1248

E66.9

ICD-10 Finland

Obesity, unspecified

5.1

125.6

272

555

A02BC03

ATC

lansoprazole; oral

2.1

123.4

1537

8507

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

4.8

122.7

284

613

N06AX22

ATC

agomelatine; oral

6.0

122.4

222

385

N05BA12

ATC

alprazolam; oral

2.9

121.4

646

2436

F34.1

ICD-10 Finland

Dysthymia

4.6

121.3

302

692

N02BF01

ATC

gabapentin; oral

2.8

120.9

668

2569

4471

FHL

Pharyngoplasty

52.9

118.9

P76

ICPC

Depressive disorder

3.2

117.8

501

1662

N02CD03

ATC

fremanezumab; systemic

37.0

117.5

A04

ICPC

Weakness/tiredness general

2.4

117.2

1004

4761

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

117.1

735

3016

N06AG02

ATC

moclobemide; oral

4.2

116.8

322

798

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

157.2

116.7

123

A02BC01

ATC

omeprazole; systemic

2.1

116.4

1508

8441

N03AF01

ATC

carbamazepine; oral, rectal

4.5

116.3

292

673

H02AB06

ATC

prednisolone; systemic

1.9

114.8

2587

17497

C07AB07

ATC

bisoprolol; oral

1.9

113.1

2468

16495

N06BA04

ATC

methylphenidate; oral

4.2

112.6

317

798

R04

ICPC

Breathing problem other

4.4

112.5

292

691

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

19.0

111.8

SPAT1377

SPAT

Polysomnography

6.7

111.8

181

280

K07.60

ICD-10 Finland

Snapping jaw

3.6

110.9

396

1176

N02CD01

ATC

erenumab; parenteral

47.0

110.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.4

110.3

291

697

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

110.2

1062

5281

SPAT1094

SPAT

Continuous Positive Airway Pressure

61.7

109.7

N06AB05

ATC

paroxetine; oral

3.4

109.4

410

1256

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

17.4

108.4

M03BX02

ATC

tizanidine; oral

1.9

107.7

3335

24763

A02BA02

ATC

ranitidine; systemic

2.3

107.6

1024

5061

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

13.1

107.6

103

N06AA06

ATC

trimipramine; systemic

5.4

107.5

219

423

C03CA01

ATC

furosemide; systemic

2.0

106.1

1488

8528

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

104.4

2367

15889

R01AD08

ATC

fluticasone; nasal

2.0

104.4

1602

9467

R40.0

ICD-10 Finland

Somnolence

24.2

104.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.9

103.8

319

855

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

101.0

2351

15865

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

100.9

688

2928

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

3.0

100.7

491

1758

SBB10

NOMESCO Finland

Dental impressions

3.0

100.0

483

1720

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.1

99.8

285

724

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.2

99.6

210

418

SPAT1240

SPAT

Therapeutic discussion

2.5

99.4

673

2853

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

99.1

1890

11962

J34.2

ICD-10 Finland

Deviated nasal septum

3.5

98.5

363

1099

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

96.3

1263

7031

M03BC01

ATC

orphenadrine (citrate); systemic

2.1

96.3

1222

6723

R52.9

ICD-10 Finland

Pain, unspecified

2.6

96.2

642

2701

G44.0

ICD-10 Finland

Cluster headache syndrome

22.9

96.2

TAB00

NOMESCO Finland

Lumbar puncture

3.8

96.1

309

854

N05AX12

ATC

aripiprazole; systemic

3.7

95.0

316

894

L03

ICPC

Low back symptom/complaint

1.9

94.9

1639

10020

R03DC03

ATC

montelukast; oral

2.2

94.8

936

4676

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

94.7

1079

5699

N05AX08

ATC

risperidone; systemic

2.8

94.5

531

2050

R52.2

ICD-10 Finland

Other chronic pain

4.1

94.4

271

691

T82

ICPC

Obesity

4.1

94.1

267

675

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

93.0

M25.5

ICD-10 Finland

Pain in joint

1.9

92.5

1823

11606

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

12.9

92.2

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

3.6

92.0

317

918

R02

ICPC

Shortness of breath/dyspnoea

2.3

91.8

764

3550

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.1

91.5

194

388

WX723, ,

SPAT

15.3

91.4

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.7

90.8

213

464

J01AA02

ATC

doxycycline; systemic

1.9

90.5

4081

33140

P01

ICPC

Feeling anxious/nervous/tense

2.2

90.4

843

4108

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

90.0

2342

16173

N02CC07

ATC

frovatriptan; oral

4.5

89.8

223

509

N05AF03

ATC

chlorprothixene; systemic

4.6

89.7

219

493

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.1

89.3

190

381

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.1

88.8

398

1356

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

88.8

1021

5399

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.6

88.3

143

221

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

88.3

1433

8550

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

86.9

350

1119

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

862.0

86.9

SPAT1051

SPAT

Guidance regarding sleep disorders

7.6

86.4

123

165

R03BA05

ATC

fluticasone; inhalant

2.1

86.3

1010

5370

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.5

86.0

213

485

L17

ICPC

Foot/toe symptom/complaint

1.8

86.0

1666

10502

Z2445

NOMESCO Finland

Psychologist

3.8

85.7

274

754

J31.0

ICD-10 Finland

Chronic rhinitis

2.6

85.5

527

2129

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

152.5

85.3

N02BE01

ATC

paracetamol; systemic, rectal

2.3

85.2

4828

41866

A01

ICPC

Pain general/multiple sites

2.5

85.0

587

2504

N03AX14

ATC

levetiracetam; systemic

8.8

84.9

107

124

DHB50

NOMESCO Finland

Turbinoplasty

5.0

84.1

184

378

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

83.9

2972

22239

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.7

83.9

479

1861

F45.8

ICD-10 Finland

Other somatoform disorders

2.8

83.9

462

1762

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

289.4

83.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

83.8

2404

16965

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

83.4

2097

14251

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.9

83.0

431

1593

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

82.9

327

1032

EB1MA

NOMESCO Finland

Cephalometry with X-ray

5.3

82.8

168

323

J45.1

ICD-10 Finland

Nonallergic asthma

2.9

82.3

425

1566

N02CC06

ATC

eletriptan; oral

4.6

81.9

199

446

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

81.7

1316

7803

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

81.4

2192

15160

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

81.2

1653

10542

N05BE01

ATC

buspirone; oral

4.2

80.9

219

534

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

80.9

3954

32240

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

80.7

1555

9749

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.9

80.1

243

644

N02BF02

ATC

pregabalin; oral

2.8

80.0

421

1566

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

79.8

1289

7642

R96

ICPC

Asthma

2.5

79.5

565

2439

N01

ICPC

Headache

2.3

79.3

660

3057

L28

ICPC

Limited function/disability (L)

2.0

79.2

967

5206

SPAT1262

SPAT

Handing over of treatment supplies

2.1

79.0

901

4731

F61.0

ICD-10 Finland

Mixed personality disorders

5.7

78.7

147

262

N06AA04

ATC

clomipramine; systemic

5.9

78.3

142

246

ZXC60

NOMESCO Finland

Application of heat

6.6

78.2

127

197

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

4.8

78.0

178

379

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

77.6

756

3735

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.2

77.3

211

518

H53.1

ICD-10 Finland

Subjective visual disturbances

2.9

77.0

395

1449

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

+∞

76.2

E66.0

ICD-10 Finland

Obesity due to excess calories

9.2

76.1

101

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

75.9

579

2579

R01AD12

ATC

fluticasone furoate; nasal

1.8

75.9

1677

10915

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

75.8

715

3484

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

75.5

1055

5948

A10BA02

ATC

metformin; oral

1.8

75.2

1424

8849

G43.8

ICD-10 Finland

Other migraine

10.7

75.2

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

74.9

442

1744

R4110, ,

SPAT

2.2

74.8

730

3605

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.2

74.8

314

1028

Z71.8

ICD-10 Finland

Other specified counselling

1.7

74.6

1914

12981

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

74.4

1024

5739

J02AC01

ATC

fluconazole; systemic

1.7

74.3

1968

13463

N06AX18

ATC

reboxetine; oral

7.7

74.2

104

137

SPAT1263

SPAT

Sampling

1.7

73.8

2164

15206

R99

ICPC

Respiratory disease other

6.2

73.7

126

206

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

73.6

287

898

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.0

72.9

341

1188

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

72.8

1188

7038

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

72.8

512

2197

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

72.7

583

2653

UJF32

NOMESCO Finland

Coloscopy

1.8

72.7

1320

8087

H03AA01

ATC

levothyroxine sodium; systemic

1.9

72.7

1140

6669

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

72.5

676

3276

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

72.5

260

772

J01DB01

ATC

cefalexin; oral

1.9

72.0

4460

38199

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

72.0

XA421

NOMESCO Finland

Nocturnal polygraphy

28.5

71.4

P01AB01

ATC

metronidazole; oral, rectal

1.7

71.3

2036

14173

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.5

71.2

177

404

A06AD11

ATC

lactulose; oral

2.1

71.0

753

3836

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.1

70.9

201

507

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.7

70.9

235

662

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.6

70.8

246

715

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

70.8

2084

14617

K30

ICD-10 Finland

Functional dyspepsia

2.2

70.5

639

3059

ZYC01

NOMESCO Finland

Remote contact by phone

2.7

70.5

389

1482

T90

ICPC

Diabetes non-insulin dependent

1.8

69.5

1219

7373

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

69.5

2950

22688

C09CA06

ATC

candesartan; oral

1.9

69.4

1184

7100

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.2

69.3

290

947

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

69.2

405

1589

ZY010

NOMESCO Finland

Hospital outpatient

2.9

68.6

343

1240

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.0

68.1

319

1112

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

67.6

459

1935

M54.2

ICD-10 Finland

Cervicalgia

2.5

67.3

459

1939

R03BB04

ATC

tiotropium bromide; inhalant

2.4

67.3

519

2319

R06AE07

ATC

cetirizine; oral

1.6

66.7

2277

16520

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.3

66.5

134

256

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

66.5

1322

8290

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.9

66.4

120

207

N02CC03

ATC

zolmitriptan; nasal, oral

3.2

66.4

272

877

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

66.1

1307

8180

L01

ICPC

Neck symptom/complaint

2.0

66.0

884

4890

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

65.9

386

1515

R11

ICD-10 Finland

Nausea and vomiting

2.4

65.4

499

2218

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

65.4

491

2167

G50.1

ICD-10 Finland

Atypical facial pain

5.4

65.0

129

243

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

65.0

1225

7555

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.5

64.9

446

1890

G04BD12

ATC

mirabegron; oral

2.2

64.9

620

3027

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.9

64.9

118

205

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.7

64.1

150

326

R03BA02

ATC

budesonide; inhalant

1.9

64.0

922

5224

R55

ICD-10 Finland

Syncope and collapse

2.2

63.7

564

2670

A10BJ02

ATC

liraglutide; parenteral

4.4

63.6

162

377

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

63.4

2459

18337

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

63.1

929

5298

Z01.2

ICD-10 Finland

Dental examination

1.6

62.9

2511

18845

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.1

62.7

275

923

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

6.1

62.4

109

182

R01AD58

ATC

fluticasone, combinations; nasal

1.8

62.4

1320

8404

G43

ICD-10 Finland

Migraine

3.1

62.3

278

942

N89

ICPC

Migraine

3.9

62.3

189

501

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

62.2

341

1293

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.8

62.1

327

1214

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.9

62.1

185

484

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.5

62.0

221

653

K02.1

ICD-10 Finland

Caries of dentine

1.6

61.9

3202

25528

J01DA01

ATC

[U] cefalexin

1.6

61.8

3141

24934

R00.2

ICD-10 Finland

Palpitations

2.4

61.7

456

1997

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.1

61.7

648

3280

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.1

61.1

170

423

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

61.1

1305

8325

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

60.8

2768

21370

R03BA08

ATC

ciclesonide; inhalant

2.4

60.7

464

2062

160

Kela drug reimbursment

exenatide

5.3

60.6

122

233

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

13.8

60.4

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

60.4

2709

20832

A28

ICPC

Limited function/disability NOS

1.9

60.3

861

4856

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

60.1

1324

8511

M01AB05

ATC

diclofenac; systemic, rectal

1.6

59.8

3363

27242

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

59.8

1526

10208

J01FA06

ATC

roxithromycin; oral

1.6

59.7

1936

13762

J01MA02

ATC

ciprofloxacin; systemic

1.6

59.7

1950

13888

SFA10

NOMESCO Finland

One-surface restoration

1.6

59.7

2951

23190

C07AB02

ATC

metoprolol; systemic

1.9

59.6

892

5105

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

59.6

287

1015

M01AH02

ATC

rofecoxib; oral

2.1

59.5

600

2988

N02CC04

ATC

rizatriptan; oral

3.0

59.3

265

899

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

59.2

1292

8279

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.3

59.2

234

738

A10BJ06

ATC

semaglutide; parenteral

3.0

59.1

276

960

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

58.9

217

655

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

58.9

742

4008

F32

ICD-10 Finland

Depressive episode

2.7

58.5

325

1240

C08CA01

ATC

amlodipine; oral

1.6

58.2

1786

12508

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.1

58.0

610

3085

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

57.9

3616

29914

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.3

57.9

223

692

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

57.8

226

708

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.7

57.5

186

515

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.5

57.4

142

323

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.7

57.3

334

1306

N05AN01

ATC

lithium; oral

3.9

57.2

174

462

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

57.1

439

1954

A03FA02

ATC

cisapride; oral, rectal

2.5

56.8

368

1515

J45.8

ICD-10 Finland

Mixed asthma

3.6

56.8

188

529

S06.0

ICD-10 Finland

Concussion

2.1

56.7

569

2825

M01AH01

ATC

celecoxib; oral

1.9

56.7

839

4779

J01FF01

ATC

clindamycin; systemic

1.7

56.7

1356

8895

N05AB03

ATC

perphenazine; systemic, rectal

3.3

56.6

223

702

J46

ICD-10 Finland

Status asthmaticus

3.9

56.4

169

444

R51

ICD-10 Finland

Headache

2.8

56.3

302

1132

IBA03

NOMESCO Finland

Psychotherapy evaluation

6.2

56.1

157

AA40B, ,

NOMESCO Finland

89.6

56.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

55.7

764

4243

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

55.7

605

3095

P99

ICPC

Psychological disorders other

3.3

55.6

211

649

M01AE02

ATC

naproxen; oral, rectal

1.6

55.4

2869

22625

S18

ICPC

Laceration/cut

1.6

55.2

2393

18122

D07AC01

ATC

betamethasone; topical

1.6

55.0

1854

13242

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

54.8

409

1796

L08

ICPC

Shoulder symptom/complaint

1.7

54.8

1172

7448

R07.3

ICD-10 Finland

Other chest pain

2.2

54.7

527

2574

R5140, ,

SPAT

6.1

54.7

161

R39.1

ICD-10 Finland

Other difficulties with micturition

3.2

54.4

223

719

R60.0

ICD-10 Finland

Localized oedema

2.0

54.2

626

3274

SFA20

NOMESCO Finland

Two-surface restoration

1.6

54.0

3091

24866

J96.1

ICD-10 Finland

Chronic respiratory failure

4.5

53.9

133

302

P74

ICPC

Anxiety disorder/anxiety state

2.7

53.9

305

1175

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

53.7

1098

6886

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.2

53.5

142

341

G93.3

ICD-10 Finland

Postviral fatigue syndrome

10.5

53.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

53.4

540

2686

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

53.2

294

1119

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

53.1

771

4358

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

53.1

493

2373

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

52.9

1516

10387

R03BA01

ATC

beclometasone; inhalant

1.9

52.9

695

3800

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

7.8

52.6

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

52.5

1073

6721

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

5.4

52.4

104

196

M48.0

ICD-10 Finland

Spinal stenosis

2.1

52.3

569

2909

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

52.3

799

4589

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

52.0

311

1231

R35

ICD-10 Finland

Polyuria

2.4

51.8

390

1718

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

51.8

482

2321

N06AB08

ATC

fluvoxamine; oral

3.7

51.8

169

471

C08DA01

ATC

verapamil; systemic

3.2

51.6

206

653

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

51.6

621

3293

D11

ICPC

Diarrhoea

1.9

51.3

671

3660

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.4

51.1

130

302

IGY02, ,

SPAT

4.3

51.1

135

323

R05

ICPC

Cough

1.7

50.8

1278

8458

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

50.7

209

676

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

50.5

1941

14225

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

50.4

628

3368

R05

ICD-10 Finland

Cough

1.7

50.3

1089

6924

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.1

50.2

107

215

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

50.1

504

2500

SPAT1301

SPAT

No procedures

1.6

50.0

1507

10426

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.2

50.0

103

201

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

49.6

705

3951

SPAT1254

SPAT

Administration of medicine

1.9

49.6

730

4138

D01

ICPC

Abdominal pain/cramps general

1.9

49.5

669

3687

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

49.5

442

2093

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

49.3

639

3472

M02AA07

ATC

piroxicam; topical

1.6

49.3

1616

11403

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

49.2

1209

7944

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.6

49.2

163

459

E0000UV, ,

ATC

1.5

49.2

2122

15930

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

49.1

601

3202

UKC02

NOMESCO Finland

Cystoscopy

1.8

48.5

805

4735

Z2446

NOMESCO Finland

Social worker

2.4

48.4

354

1539

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

7.8

48.0

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

48.0

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

48.0

370

1647

J01FA10

ATC

azithromycin; systemic

1.5

47.9

2907

23414

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

47.8

3785

32258

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

47.8

1132

7360

R5110, ,

SPAT

2.2

47.1

426

2026

M01AH05

ATC

etoricoxib; oral

1.5

46.9

3115

25516

SPAT1310

SPAT

Counselling related to known health issue

1.6

46.8

1529

10752

N06AA10

ATC

nortriptyline; systemic

4.6

46.8

113

252

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

46.8

668

3746

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

46.6

550

2892

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

46.4

1537

10842

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

46.2

696

3969

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

46.1

287

1158

A10BX07

ATC

[U] liraglutide

6.3

45.7

124

N30.0

ICD-10 Finland

Acute cystitis

1.8

45.6

826

4979

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

45.6

598

3260

E66

ICD-10 Finland

Obesity

2.6

45.5

268

1052

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.4

45.5

114

262

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.9

45.4

134

348

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

45.3

1494

10514

H02AB07

ATC

prednisone; oral

1.9

45.3

643

3596

G04BD08

ATC

solifenacin; oral

2.4

45.3

319

1363

KMAK, ,

NOMESCO Finland

1.5

45.2

2617

20775

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.5

44.9

157

J01CA04

ATC

amoxicillin; systemic

1.6

44.9

4323

38189

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

6.3

44.8

120

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

44.7

1360

9387

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

44.7

395

1860

G04CA02

ATC

tamsulosin; oral

1.6

44.5

1199

8036

F33.8

ICD-10 Finland

Other recurrent depressive disorders

6.0

44.4

131

SPAT1312

SPAT

General health counselling

1.6

44.2

1569

11220

C10AA05

ATC

atorvastatin; oral

1.5

44.1

1886

14043

R06AX27

ATC

desloratadine; oral

1.6

44.0

1444

10142

R01AD01

ATC

beclometasone; nasal

1.8

43.9

748

4426

SAA04

NOMESCO Finland

Special examination of mouth

2.5

43.9

294

1228

R03AC03

ATC

terbutaline; inhalant

1.9

43.8

668

3821

A02BC04

ATC

rabeprazole; oral

2.1

43.8

442

2193

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

6.2

43.7

123

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

43.7

519

2733

K59.0

ICD-10 Finland

Constipation

2.5

43.6

294

1231

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

43.6

2080

15836

B01AC04

ATC

clopidogrel; oral

1.8

43.5

674

3873

G47

ICD-10 Finland

Sleep disorders

16.2

43.5

F51

ICD-10 Finland

Nonorganic sleep disorders

2.5

43.4

272

1101

P20

ICPC

Memory disturbance

1.9

43.4

603

3348

Z3231

NOMESCO Finland

Registered nurse

1.6

43.4

1303

8959

M35.7

ICD-10 Finland

Hypermobility syndrome

4.7

43.3

100

215

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.4

43.3

160

484

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.3

43.3

164

504

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

43.1

398

1907

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.8

43.1

135

366

OAB50, ,

SPAT

2.2

43.1

403

1941

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.0

43.1

125

321

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

42.9

454

2292

M03BX01

ATC

baclofen; systemic

4.0

42.8

124

318

205

Kela drug reimbursment

Chronic hypertension

1.6

42.8

1119

7436

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

42.7

279

1151

N02CC05

ATC

almotriptan; oral

3.3

42.7

168

528

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

42.6

819

5015

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

42.6

1863

13911

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.8

42.5

133

360

J45

ICD-10 Finland

Asthma

2.0

42.5

516

2736

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

42.5

178

581

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

42.5

964

6176

SFA30

NOMESCO Finland

Three-surface restoration

1.5

42.5

2118

16247

XKD00

NOMESCO Finland

Uroflowmetry

1.7

42.4

812

4968

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

42.2

490

2557

G45.4

ICD-10 Finland

Transient global amnesia

10.5

42.0

H02AB04

ATC

methylprednisolone; systemic

1.8

41.9

669

3877

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.8

41.9

128

341

SPAT1260

SPAT

Consultation of another employee

1.7

41.9

831

5133

-1, ,

NOMESCO Finland

1.5

41.8

1701

12500

A08AB01

ATC

orlistat; oral

8.1

41.8

3074F

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIVALVERYTMIN HÄIRIÖ]

+∞

41.7

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

41.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

41.6

294

1258

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

41.5

297

1278

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.7

41.3

134

372

R51.81

ICD-10 Finland

Facial pain NOS

3.6

41.2

136

382

A11

ICPC

Chest pain NOS

2.1

41.1

422

2105

L86

ICPC

Back syndrome with radiating pain

2.3

40.9

316

1406

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

40.9

373

1778

SPAT1229

SPAT

Assessment of need for aid

2.3

40.9

338

1548

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

40.8

1153

7795

M03AX01

ATC

botulinum toxin; parenteral

5.0

40.8

175

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

40.8

639

3682

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

40.7

1467

10487

R13

ICD-10 Finland

Dysphagia

2.2

40.6

348

1618

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.9

40.5

120

313

R25.1

ICD-10 Finland

Tremor, unspecified

3.0

40.4

179

604

M01AX17

ATC

nimesulide; oral

1.6

40.3

1029

6786

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

40.1

901

5749

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

40.1

266

1106

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

40.0

1063

7076

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.5

40.0

268

1119

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

40.0

1069

7128

S29

ICPC

Skin symptom/complaint other

1.6

39.9

1035

6849

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.5

39.9

222

SPAT1097

SPAT

Recording of ECG

1.8

39.8

629

3633

A10AE04

ATC

insulin glargine; parenteral

2.0

39.7

482

2553

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.1

39.7

169

557

C01DA14

ATC

isosorbide mononitrate; oral

1.8

39.6

643

3742

L15

ICPC

Knee symptom/complaint

1.6

39.4

1191

8172

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

39.4

559

3120

XG460

NOMESCO Finland

Short time oxymetry

4.5

39.4

216

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.7

39.3

124

338

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

39.3

1330

9367

A10BH01

ATC

sitagliptin; oral

2.0

39.2

443

2289

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

39.0

931

6029

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

5.6

39.0

134

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

39.0

452

2357

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

4.7

38.9

194

Z00.0

ICD-10 Finland

General medical examination

1.6

38.9

964

6303

G44.8

ICD-10 Finland

Other specified headache syndromes

5.6

38.8

131

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

38.8

483

2581

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.2

38.7

153

C08CA13

ATC

lercanidipine; oral

1.8

38.6

623

3620

A29

ICPC

General symptom/complaint other

1.8

38.3

670

3986

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

4.3

38.1

234

AA400

NOMESCO Finland

Electroconvulsive therapy

6.2

38.1

106

J01FA09

ATC

clarithromycin; systemic

1.5

38.1

1466

10604

ZXD20

NOMESCO Finland

Day surgery

1.8

38.1

633

3709

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

38.0

431

2228

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

38.0

191

691

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

38.0

224

880

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.8

37.9

199

737

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

37.9

558

3150

J01MA12

ATC

levofloxacin; systemic

1.7

37.8

857

5473

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

37.6

1943

14911

ZXA10

NOMESCO Finland

Bilateral

1.7

37.6

846

5393

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

37.6

232

932

C05AA08

ATC

fluocortolone; rectal, topical

1.8

37.6

636

3746

XF402

NOMESCO Finland

ECG with work load test

2.0

37.5

468

2502

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

37.4

640

3782

WZC00, ,

SPAT

1.7

37.4

765

4755

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.7

37.3

201

754

N06AX17

ATC

milnacipran; oral

5.7

37.3

122

C10AA01

ATC

simvastatin; oral

1.5

37.2

1744

13122

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

36.9

1015

6798

162

Kela drug reimbursment

liraglutide

5.8

36.7

117

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

5.6

36.7

124

WX290

NOMESCO Finland

Other blockage of nerve

1.4

36.6

2467

19875

K08.80

ICD-10 Finland

Toothache NOS

1.9

36.5

463

2488

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

36.5

N06BA12

ATC

lisdexamfetamine; oral

4.3

36.4

217

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

6.2

36.4

101

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

36.4

612

3596

F60.5

ICD-10 Finland

Anankastic personality disorder

4.7

36.4

177

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

36.4

688

4182

N17

ICPC

Vertigo/dizziness

1.8

36.3

593

3454

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

36.3

334

1597

F33

ICD-10 Finland

Recurrent depressive disorder

3.2

36.2

146

466

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.1

36.1

151

493

R74

ICPC

Upper respiratory infection acute

1.5

36.0

1687

12673

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

35.9

328

1564

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.7

35.8

195

736

Z00.8

ICD-10 Finland

Other general examinations

2.0

35.6

419

2194

SPAT1058

SPAT

PEF monitoring instruction

2.1

35.6

371

1860

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

35.5

1318

9435

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.7

35.5

201

774

214

Kela drug reimbursment

Severe and chronic narcolepsy

+∞

35.4

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.2

35.4

139

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

35.4

167

584

C10AA07

ATC

rosuvastatin; oral

1.5

35.3

1520

11219

A46

ICD-10 Finland

Erysipelas

1.7

35.3

689

4223

XQ800

NOMESCO Finland

Prick test

2.1

35.3

363

1811

N05CD02

ATC

nitrazepam; oral

4.3

35.1

215

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.1

35.0

148

486

SPAT1216

SPAT

Assessment of functional ability

1.7

34.6

650

3940

D07AD01

ATC

clobetasol; topical

1.7

34.5

792

5067

R03DA04

ATC

theophylline; systemic, rectal

2.4

34.5

235

989

C03DA01

ATC

spironolactone; oral

1.8

34.2

543

3133

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.6

34.2

198

771

C09CA01

ATC

losartan; oral

1.5

34.1

1132

7903

Z01.7

ICD-10 Finland

Laboratory examination

1.6

34.1

852

5567

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

34.1

1624

12215

L12

ICPC

Hand/finger symptom/complaint

1.6

34.0

854

5587

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

33.9

752

4767

M01AC06

ATC

meloxicam; systemic, rectal

1.5

33.9

1611

12109

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

33.8

589

3492

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

33.8

658

4026

R29

ICPC

Respiratory symptom/complaint other

2.1

33.8

336

1655

L13

ICPC

Hip symptom/complaint

1.6

33.8

855

5603

ZXA05

NOMESCO Finland

Left side

1.6

33.6

1086

7533

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

33.6

174

640

4211

FHL

Transeptal septal resection and reconstruction

5.5

33.6

120

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

33.5

230

971

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.9

33.4

150

R21

ICPC

Throat symptom/complaint

1.5

33.3

1089

7572

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

33.3

978

6638

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

33.3

136

438

N02AA05

ATC

oxycodone; systemic

1.6

33.2

816

5306

IHZ05, ,

SPAT

2.3

33.2

253

1119

PA6AD

NOMESCO Finland

CT of neck arteries

3.0

33.1

147

497

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

32.9

370

1906

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.5

32.9

219

912

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

44.7

32.8

U02

ICPC

Urinary frequency/urgency

1.7

32.6

680

4237

A10AB05

ATC

insulin aspart; parenteral

2.0

32.6

375

1947

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

5.9

32.5

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

32.5

216

899

K03.00

ICD-10 Finland

Approximal wear

1.9

32.4

421

2278

T83

ICPC

Overweight

3.2

32.4

129

409

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

32.4

521

3017

N07BB01

ATC

disulfiram; oral

2.4

32.3

231

993

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.9

32.2

147

G54.0

ICD-10 Finland

Brachial plexus disorders

3.1

32.2

136

447

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.6

31.9

104

290

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

31.9

1154

8191

R03AC12

ATC

salmeterol; inhalant

2.5

31.9

203

828

F41.00

ICD-10 Finland

Moderate panic disorder

3.7

31.8

100

272

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

31.8

573

3429

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

31.8

217

914

N02CD02

ATC

galcanezumab; parenteral

88.1

31.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

31.6

1610

12227

XG405

NOMESCO Finland

Education on PEF monitoring

4.0

31.5

229

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.6

31.4

191

762

ZXA00

NOMESCO Finland

Right side

1.5

31.3

1152

8200

Z08

ICPC

Social welfare problem

4.0

31.3

221

M54.8

ICD-10 Finland

Other dorsalgia

2.3

31.3

235

1032

WX780, ,

SPAT

9.8

31.2

R06AX22

ATC

ebastine; oral

1.6

31.1

773

5034

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.1

30.9

301

1470

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

30.8

589

3582

J01EA01

ATC

trimethoprim; systemic

1.5

30.8

1101

7789

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

6.5

30.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

30.5

3455

30051

A10BK03

ATC

empagliflozin; oral

1.8

30.5

466

2655

R49.01

ICD-10 Finland

Functional dysphonia

2.8

30.4

155

565

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.9

30.4

135

NOMESCO Finland

Other rehabilitation services

+∞

30.2

A02BA04

ATC

nizatidine; systemic

2.1

30.0

314

1575

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.3

29.7

225

992

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

29.7

481

2788

GX2D5

NOMESCO Finland

Sleep oximetry

7.5

29.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

29.7

211

905

R06.2

ICD-10 Finland

Wheezing

2.3

29.6

223

981

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

29.5

278

1340

N05AF01

ATC

flupentixol; systemic

3.9

29.5

222

EBA00

NOMESCO Finland

Extraction of tooth

1.4

29.5

1839

14445

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

29.4

648

4090

R12

ICD-10 Finland

Heartburn

1.9

29.4

401

2204

C02AC05

ATC

moxonidine; oral

2.4

29.3

197

824

C10AA03

ATC

pravastatin; oral

2.1

29.2

294

1453

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

6.9

29.2

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

29.2

238

1083

WVA30, ,

SPAT

2.0

29.2

338

1759

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

29.1

417

2327

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

29.1

219

963

R41.0

ICD-10 Finland

Disorientation, unspecified

2.9

29.1

141

501

R07.0

ICD-10 Finland

Pain in throat

1.9

29.0

369

1983

R52.1

ICD-10 Finland

Chronic intractable pain

5.1

28.9

118

XF404

NOMESCO Finland

Ambulatory ECG

1.9

28.9

374

2021

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

28.8

915

6299

C08DB01

ATC

diltiazem; oral

2.4

28.8

208

899

J20

ICD-10 Finland

Acute bronchitis

1.8

28.7

482

2823

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.8

28.7

142

510

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

28.7

2506

20795

P25

ICPC

Phase of life problem adult

2.3

28.6

228

1027

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

28.6

199

845

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

28.6

468

2720

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

28.6

181

736

R03AC13

ATC

formoterol; inhalant

2.3

28.6

220

977

A01AB09

ATC

miconazole; local oral

1.9

28.5

366

1971

M04AA01

ATC

allopurinol; systemic

1.7

28.4

568

3494

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

28.4

244

1135

IHZ04, ,

SPAT

3.4

28.3

104

314

A10BB12

ATC

glimepiride; oral

2.1

28.3

287

1423

C03AA03

ATC

hydrochlorothiazide; oral

1.9

28.3

353

1884

K80

ICPC

Cardiac arrhythmia NOS

1.9

28.3

389

2144

K07.61

ICD-10 Finland

Cracking jaw joint

3.0

28.2

128

438

EB1VA, ,

NOMESCO Finland

1.6

28.2

863

5892

N02CC02

ATC

naratriptan; oral

4.3

28.1

173

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.8

28.1

230

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.8

27.9

231

R50.9

ICD-10 Finland

Fever, unspecified

1.6

27.9

729

4797

N05AL01

ATC

sulpiride; systemic

3.8

27.9

222

E000001, ,

ATC

1.5

27.9

920

6382

H93.1

ICD-10 Finland

Tinnitus

1.9

27.9

339

1793

A10BJ05

ATC

dulaglutide; parenteral

3.6

27.9

259

K04

ICPC

Palpitations/awareness of heart

2.1

27.8

262

1263

H57.1

ICD-10 Finland

Ocular pain

2.4

27.8

199

856

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

27.8

279

1378

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.5

27.8

175

710

L60.0

ICD-10 Finland

Ingrowing nail

2.2

27.7

239

1113

C01CA24

ATC

epinephrine; parenteral

2.0

27.7

297

1503

G40

ICD-10 Finland

Epilepsy

100.6

27.7

D09

ICPC

Nausea

2.2

27.6

246

1160

H02AB09

ATC

hydrocortisone; systemic

3.0

27.6

126

433

X58

ICD-10 Finland

Exposure to other specified factors

1.6

27.6

718

4719

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

11.2

27.5

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

4.8

27.5

131

OAB72

NOMESCO Finland

Weight control and weight loss guidance

5.8

27.5

Z3226

NOMESCO Finland

Physiotherapist

1.6

27.5

798

5380

J01DA06

ATC

[U] cefuroxime

1.6

27.5

634

4047

SPAT1234

SPAT

Support of social functional capacity

2.2

27.4

233

1079

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.3

27.3

105

326

C09AA02

ATC

enalapril; systemic

1.6

27.3

795

5362

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.7

27.3

144

535

XKC03

NOMESCO Finland

Water cystometry

2.8

27.3

139

507

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

27.2

212

946

D02

ICPC

Abdominal pain epigastric

2.0

27.2

302

1548

SJB60

NOMESCO Finland

Adjustment and grinding of removable appliance

3.7

27.2

240

R25.2

ICD-10 Finland

Cramp and spasm

2.9

27.2

131

464

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

27.2

278

1383

L02

ICPC

Back symptom/complaint

1.7

27.1

496

2976

J01DA09

ATC

[U] cefadroxil

1.5

27.1

1205

8875

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

+∞

27.1

A07AA02

ATC

nystatin; oral

2.1

27.0

252

1210

D06

ICPC

Abdominal pain localized other

1.8

27.0

438

2538

N05AD01

ATC

haloperidol; systemic

2.6

26.8

158

621

R4110

NOMESCO Finland

Physiotherapy

1.4

26.8

1286

9607

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.5

26.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

26.7

1426

10858

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

26.7

483

2890

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.7

26.6

144

542

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.2

26.5

238

1126

D19

ICPC

Teeth/gum symptom/complaint

1.4

26.5

1529

11801

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

26.5

137

504

R06AE09

ATC

levocetirizine; oral

1.6

26.5

661

4300

G04BD07

ATC

tolterodine; oral

2.3

26.4

201

888

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

26.4

278

1397

M01AB55

ATC

diclofenac, combinations; oral

2.1

26.4

272

1356

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

26.3

669

4370

J01CA08

ATC

pivmecillinam; oral

1.4

26.3

1695

13327

SPAT1153

SPAT

Removal of sutures

1.4

26.3

1372

10402

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

26.2

117

397

H02

ICPC

Hearing complaint

1.6

26.2

645

4180

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

26.2

736

4923

ZY000

NOMESCO Finland

Hospital inpatient

3.8

26.1

214

G04BD09

ATC

trospium; oral

3.1

26.1

110

361

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

26.1

797

5429

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.1

26.1

106

K04.08

ICD-10 Finland

Other specified pulpit

1.8

26.1

391

2212

282

Kela drug reimbursment

Sodium oxybat

+∞

26.1

G40.10

ICD-10 Finland

Simple partial seizures

+∞

26.1

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

26.1

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.4

26.0

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

26.0

257

1263

M01AH03

ATC

valdecoxib; oral

2.1

25.9

268

1338

WZC30

NOMESCO Finland

Teaching

1.6

25.9

767

5188

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.0

25.9

118

405

R41.3

ICD-10 Finland

Other amnesia

2.8

25.9

129

465

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

31.1

25.9

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

25.9

1429

10937

F32.8

ICD-10 Finland

Other depressive episodes

3.3

25.8

297

RK320, ,

NOMESCO Finland

7.2

25.8

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

25.8

605

3874

M02AA10

ATC

ketoprofen; topical

1.6

25.7

670

4401

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

25.7

221

1028

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.5

25.7

259

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

93.9

25.7

U07

ICPC

Urine symptom/complaint other

1.8

25.6

394

2247

R01AD11

ATC

triamcinolone; nasal

1.8

25.6

378

2129

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.8

25.6

126

452

SGA01

NOMESCO Finland

Emergency treatment

1.5

25.5

782

5331

A02BX02

ATC

sucralfate; oral

2.5

25.5

168

697

L18

ICPC

Muscle pain

2.2

25.4

210

961

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

25.4

243

1179

H01

ICPC

Ear pain/earache

1.6

25.4

565

3570

A10BK01

ATC

dapagliflozin; oral

1.9

25.4

352

1944

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

25.3

144

556

R06.4

ICD-10 Finland

Hyperventilation

3.6

25.3

228

N03AX18

ATC

lacosamide; systemic

50.2

25.2

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

25.0

1368

10441

A99

ICPC

Disease/condition unspecnature/site

1.7

25.0

483

2940

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

25.0

150

595

M54

ICD-10 Finland

Dorsalgia

1.6

25.0

591

3791

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

9.7

25.0

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.2

24.9

218

1021

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

24.9

382

2176

F06.7

ICD-10 Finland

Mild cognitive disorder

2.7

24.9

135

509

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.7

24.9

217

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.1

24.8

168

S80.0

ICD-10 Finland

Contusion of knee

1.8

24.8

354

1973

N06BA09

ATC

atomoxetine; oral

6.3

24.8

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

5.4

24.7

M01AX05

ATC

glucosamine; oral

1.6

24.7

715

4809

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

4.6

24.7

127

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

251.3

24.7

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

5.3

24.6

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.1

24.5

161

R5599

NOMESCO Finland

Other rehabilitation service

2.7

24.4

136

520

N06AA22, ,

ATC

5.8

24.4

F51.5

ICD-10 Finland

Nightmares

24.4

24.3

SFA00

NOMESCO Finland

Small restoration

1.6

24.3

670

4456

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.9

24.3

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

24.3

362

2045

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

24.3

1267

9584

S97

ICPC

Chronic ulcer skin

2.0

24.2

283

1476

A01AB04

ATC

amphotericin B; local oral

2.3

24.2

184

813

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

6.7

24.2

N39.3

ICD-10 Finland

Stress incontinence

2.0

24.2

289

1520

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

24.2

153

623

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

7.3

24.1

A97

ICPC

No disease

1.5

24.1

967

6963

H02.3

ICD-10 Finland

Blepharochalasis

2.0

24.0

276

1431

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

24.0

197

899

N07XX04

ATC

sodium oxybate; oral

+∞

24.0

G04CA01

ATC

alfuzosin; oral

1.6

23.9

583

3766

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.3

23.9

147

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

6.4

23.9

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

23.9

441

2651

B01AB05

ATC

enoxaparin; parenteral

1.4

23.8

1353

10379

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

23.8

703

4747

AN1

Coronary angiography

1.7

23.8

441

2653

S02

ICPC

Pruritus

2.3

23.8

183

813

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

4.7

23.8

119

J01AA07

ATC

tetracycline; systemic

1.6

23.8

681

4568

R03BC03

ATC

nedocromil; inhalant

1.9

23.7

286

1508

R5599, ,

SPAT

7.2

23.7

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

23.7

333

1846

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.8

23.6

115

410

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.1

23.5

325

SPAT1053

SPAT

Memory test

1.6

23.5

522

3293

SPAT1325

SPAT

Vaccination

1.4

23.5

1465

11410

Z29

ICPC

Social problem NOS

2.7

23.5

125

467

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

23.4

161

681

SDA03

NOMESCO Finland

Periodontal treatment

1.3

23.4

1997

16342

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.4

23.3

241

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

23.3

831

5841

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

23.3

471

2901

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

23.3

325

1798

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

23.2

365

2094

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.4

23.2

156

653

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

23.2

340

1910

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

23.2

151

623

F31

ICD-10 Finland

Bipolar affective disorder

3.7

23.1

200

A10BJ01

ATC

exenatide; parenteral

4.6

23.1

118

B02AA02

ATC

tranexamic acid; systemic

1.6

23.0

624

4132

A03

ICPC

Fever

1.5

23.0

848

6001

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

23.0

531

3384

UDC00

NOMESCO Finland

Ear microscopy

1.8

22.9

331

1851

A10BX04

ATC

[U] exenatide

4.6

22.8

115

R06AX13

ATC

loratadine; oral

1.6

22.8

669

4508

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

22.7

301

1638

ZXY60

NOMESCO Finland

2-person team, nurses

5.8

22.7

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.3

22.7

175

779

D01AC02

ATC

miconazole; topical

1.8

22.6

332

1866

D07XC01

ATC

betamethasone; topical

1.6

22.6

537

3445

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

22.6

210

1008

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

22.6

290

1562

OAB42, ,

SPAT

1.6

22.6

620

4117

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.0

22.5

101

344

R03BB01

ATC

ipratropium bromide; inhalant

2.4

22.5

154

650

IGV01

NOMESCO Finland

Psychiatric network contact

3.7

22.5

199

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

22.5

521

3322

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

22.5

147

608

K07.13

ICD-10 Finland

Retrognaty, mandibular

3.5

22.4

228

N62

ICD-10 Finland

Hypertrophy of breast

2.2

22.4

189

873

SXC05

NOMESCO Finland

Other oral or dental procedure

1.8

22.4

324

1813

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

4.1

22.4

146

R01AD05

ATC

budesonide; nasal

1.8

22.3

324

1814

EMB10

NOMESCO Finland

Tonsillectomy

1.9

22.3

279

1489

L29

ICPC

Musculoskeletal sympt/complt other

1.7

22.3

402

2399

W19

ICD-10 Finland

Unspecified fall

1.7

22.2

441

2701

A05

ICPC

Feeling ill

1.9

22.2

294

1599

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

22.2

725

5000

ZXD05

NOMESCO Finland

Urgent procedure

1.4

22.1

1368

10622

C10AC01

ATC

colestyramine; oral

2.6

22.1

128

499

M54.3

ICD-10 Finland

Sciatica

1.9

22.1

264

1387

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

22.1

606

4021

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

22.1

1696

13628

F61

ICD-10 Finland

Mixed and other personality disorders

6.6

22.1

S22.3

ICD-10 Finland

Fracture of rib

1.8

22.1

332

1880

A06AC51

ATC

ispaghula, combinations; oral

2.1

22.0

206

991

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.5

22.0

144

596

3051, ,

Kela drug reimbursment

4.9

22.0

A10AC01

ATC

insulin (human); parenteral

1.8

22.0

325

1831

M43.1

ICD-10 Finland

Spondylolisthesis

2.3

22.0

171

764

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

21.9

416

2518

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

21.9

115

427

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.9

21.9

166

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.7

21.8

117

439

U04

ICPC

Incontinence urine

2.0

21.8

238

1212

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

21.8

206

995

B01AA03

ATC

warfarin; systemic

1.5

21.7

728

5047

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

21.6

1338

10385

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.1

21.5

A08

ICPC

Swelling

2.0

21.5

237

1211

ZXC10

NOMESCO Finland

Use of laser

2.8

21.5

110

403

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

21.5

557

3647

F29

ICPC

Eye symptom/complaint other

1.6

21.5

492

3127

IER01

NOMESCO Finland

Psychoeducation, group

4.1

21.5

142

N05AE04

ATC

ziprasidone; systemic

5.1

21.4

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.1

21.4

296

K07

ICPC

Swollen ankles/oedema

2.1

21.3

200

963

N05AX15

ATC

cariprazine; oral

6.4

21.3

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

21.3

993

7339

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

21.2

160

705

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

5.2

21.2

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.2

21.2

135

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

21.1

1043

7790

M10.9

ICD-10 Finland

Gout, unspecified

1.8

21.0

298

1656

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

21.0

519

3359

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.2

21.0

268

K89

ICPC

Transient cerebral ischaemia

6.3

21.0

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

21.0

391

2355

K04.0

ICD-10 Finland

Pulpitis

1.7

21.0

426

2626

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.5

21.0

204

C08CA02

ATC

felodipine; oral

1.7

20.9

363

2144

L04

ICPC

Chest symptom/complaint

1.9

20.9

289

1595

H53.2

ICD-10 Finland

Diplopia

2.5

20.8

134

550

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

20.8

G41.9

ICD-10 Finland

Status epilepticus, unspecified

+∞

20.8

F51.1

ICD-10 Finland

Nonorganic hypersomnia

17.9

20.8

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

20.8

235

1212

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

20.8

235

1213

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.9

20.7

265

1425

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

20.7

255

1354

H81.3

ICD-10 Finland

Other peripheral vertigo

2.6

20.7

123

486

K07.4

ICD-10 Finland

Malocclusion, unspecified

3.1

20.7

291

N04BC04

ATC

ropinirole; oral

3.7

20.7

182

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.7

20.7

112

423

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.0

20.6

142

SPAT1284

SPAT

Extensive health certificate

2.5

20.6

133

547

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

20.4

134

555

N05AB04

ATC

prochlorperazine; systemic, rectal

3.1

20.4

283

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

5.9

20.4

QDH05

NOMESCO Finland

Correction of deformity of toe nail

6.7

20.4

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

20.4

269

1462

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.3

20.4

122

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.7

20.3

107

398

M54.1

ICD-10 Finland

Radiculopathy

2.2

20.3

176

822

D01BA02

ATC

terbinafine; oral

1.4

20.3

1149

8775

L14

ICPC

Leg/thigh symptom/complaint

1.7

20.3

357

2116

D07AC13

ATC

mometasone; topical

1.4

20.3

1281

9960

ACC51

NOMESCO Finland

Release of median nerve

1.8

20.2

315

1802

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.6

20.2

115

445

N02AJ13

ATC

tramadol and paracetamol; systemic

2.8

20.2

100

360

S22

ICPC

Nail symptom/complaint

1.8

20.2

316

1810

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.0

20.2

301

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

20.1

297

1672

F84.5

ICD-10 Finland

Asperger syndrome

4.9

20.1

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

20.1

627

4279

SPAT1059

SPAT

Spirometry at the office

2.0

20.0

213

1075

R4190

NOMESCO Finland

Nutritional therapy

2.1

20.0

189

913

SPAT1238

SPAT

Brief therapy

3.0

20.0

297

R4120

NOMESCO Finland

Occupational therapy

1.8

20.0

284

1580

R52.0

ICD-10 Finland

Acute pain

2.3

20.0

158

711

N02CD06

ATC

rimegepant; oral

18.8

19.9

F45.0

ICD-10 Finland

Somatization disorder

7.0

19.9

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

19.8

407

2514

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

19.8

265

1447

J01FA01

ATC

erythromycin; systemic

1.5

19.8

619

4225

N04BD01

ATC

selegiline; oral

3.2

19.8

252

H29

ICPC

Ear symptom/complaint other

1.6

19.7

541

3587

F50.8

ICD-10 Finland

Other eating disorders

6.3

19.7

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.2

19.7

121

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

19.7

637

4379

SPAT1255

SPAT

Intravenous administration of medicine

1.8

19.7

290

1632

D02AE01

ATC

carbamide; topical

1.8

19.6

284

1589

SPAT1139

SPAT

Nutrition survey

2.4

19.6

139

597

A27

ICPC

Fear of other disease NOS

1.9

19.6

232

1217

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

19.5

293

1658

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

3.9

19.4

144

N05CD08

ATC

midazolam; nasal, systemic

2.8

19.4

335

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

19.3

192

946

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.2

19.3

123

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.7

19.3

163

U01

ICPC

Dysuria/painful urination

1.7

19.2

336

1987

N88

ICPC

Epilepsy

46.2

19.2

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.6

19.1

173

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

7.9

19.1

F41.01

ICD-10 Finland

Severe panic disorder

4.8

19.1

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.7

19.1

105

400

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

19.1

434

2753

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.2

19.0

167

784

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.3

19.0

116

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

19.0

507

3341

J30.3

ICD-10 Finland

Other allergic rhinitis

2.2

18.9

169

799

IHZ01, ,

SPAT

3.3

18.9

213

E000006, ,

ATC

1.8

18.9

275

1541

H13

ICPC

Plugged feeling ear

1.4

18.9

863

6341

SJB10

NOMESCO Finland

Fitting of removable appliance incl. patient instructions, demanding

4.5

18.9

104

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

18.9

307

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

18.9

391

2422

U71

ICPC

Cystitis/urinary infection other

1.8

18.8

287

1631

N05AB01

ATC

dixyrazine; systemic

3.4

18.8

194

ICB06, ,

NOMESCO Finland

4.2

18.8

121

R44.1

ICD-10 Finland

Visual hallucinations

5.8

18.8

C07AG02

ATC

carvedilol; oral

1.9

18.8

224

1177

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

18.8

550

3698

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

18.8

292

1670

34609

ICD-8 Finland

Migraine, Unspecified

+∞

18.8

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

18.8

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.3

18.7

139

609

P18

ICPC

Medication abuse

4.3

18.7

113

207

Kela drug reimbursment

Chronic arrhythmias

1.5

18.7

603

4140

G43.2

ICD-10 Finland

Status migrainosus

70.1

18.7

OAB72, ,

SPAT

3.3

18.7

220

A10AE05

ATC

insulin detemir; parenteral

1.9

18.6

232

1237

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.6

18.6

167

R03CA02

ATC

ephedrine; oral

20.9

18.6

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

18.5

576

3923

S21

ICPC

Skin texture symptom/complaint

1.5

18.5

686

4843

I50.0

ICD-10 Finland

Congestive heart failure

1.8

18.5

272

1529

N07CA01

ATC

betahistine; oral

1.8

18.5

284

1618

S82

ICPC

Naevus/mole

1.5

18.4

658

4612

N05CD05

ATC

triazolam; oral, sublingual

3.5

18.3

183

U05

ICPC

Urination problems other

1.9

18.3

236

1274

R04.2

ICD-10 Finland

Haemoptysis

2.2

18.2

151

693

OAB93, ,

SPAT

1.8

18.2

301

1752

N03AX15

ATC

zonisamide; oral

44.1

18.2

N29

ICPC

Neurological sympt/complt other

2.8

18.2

330

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

18.2

127

542

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

2.7

18.1

353

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

18.1

289

1666

J05AB01

ATC

aciclovir; systemic

1.4

18.1

942

7078

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

18.1

450

2916

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

18.0

113

459

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

6.3

18.0

R30.0

ICD-10 Finland

Dysuria

2.0

17.9

203

1048

C09AA05

ATC

ramipril; oral

1.4

17.9

981

7432

F40.1

ICD-10 Finland

Social phobias

2.4

17.9

128

552

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.6

17.9

102

396

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.2

17.9

113

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

3.8

17.8

144

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

17.8

286

1651

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

17.8

226

1213

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.6

17.8

100

385

R30.1

ICD-10 Finland

Vesical tenesmus

2.6

17.8

101

391

SPAT1283

SPAT

Restricted health certificate

1.4

17.8

789

5764

Z73.0

ICD-10 Finland

Burn-out

2.0

17.7

191

969

IEV99

NOMESCO Finland

Other psychiatric network intervention

4.5

17.7

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

17.7

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

17.7

886

6612

H92.0

ICD-10 Finland

Otalgia

1.8

17.7

287

1663

K11.2

ICD-10 Finland

Sialoadenitis

2.2

17.6

152

710

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

17.6

195

1000

D12

ICPC

Constipation

2.1

17.5

170

830

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

17.5

365

R31

ICD-10 Finland

Unspecified haematuria

1.6

17.5

437

2832

IEY05, ,

SPAT

6.3

17.5

L16

ICPC

Ankle symptom/complaint

1.5

17.5

523

3530

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

180.6

17.5

WX002

NOMESCO Finland

Sedation and analgesia

1.4

17.5

793

5812

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.6

17.5

484

3213

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

17.5

1086

8395

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

17.4

321

1926

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

17.4

274

1572

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

17.4

217

1158

WX402

NOMESCO Finland

General anaesthesia

1.4

17.4

1021

7823

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

17.3

254

1428

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.8

17.3

138

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

17.3

125

542

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

17.3

570

3930

R33

ICD-10 Finland

Retention of urine

1.7

17.3

350

2155

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

17.2

257

1452

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

17.2

241

1335

IEY01

NOMESCO Finland

Psychoeducation, individual

3.9

17.2

125

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.8

17.2

312

D82

ICPC

Teeth/gum disease

1.3

17.2

1783

14830

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

17.2

474

3145

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.7

17.2

148

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

17.1

254

1432

R19.4

ICD-10 Finland

Change in bowel habit

2.2

17.1

139

634

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

17.0

267

1531

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

17.0

256

1450

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.2

17.0

137

622

F32.0

ICD-10 Finland

Mild depressive episode

2.3

17.0

134

603

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.7

17.0

354

J01MA14

ATC

moxifloxacin; systemic

1.6

16.9

375

2361

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

16.9

980

7485

S04

ICPC

Lump/swelling localized

1.5

16.9

507

3424

B01AC07

ATC

dipyridamole; systemic

2.3

16.9

125

547

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

16.9

4649

43833

E29.1

ICD-10 Finland

Testicular hypofunction

3.2

16.9

203

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

16.9

171

849

C08CA05

ATC

nifedipine; systemic

1.8

16.9

234

1293

N30

ICD-10 Finland

Cystitis

1.7

16.9

348

2153

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

16.8

266

1529

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.2

16.8

141

651

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

16.8

162

790

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.4

16.8

179

C10AX09

ATC

ezetimibe; oral

1.5

16.8

658

4694

K02

ICPC

Pressure/tightness of heart

2.6

16.8

391

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.4

16.8

112

469

C10AA04

ATC

fluvastatin; oral

1.7

16.7

310

1865

3074G

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNISSAKÄVELYHÄIRIÖ JA YÖLLINEN KAUHUKOHTAUS]

+∞

16.7

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.7

16.7

323

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

16.7

122

532

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

35.1

16.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.8

16.6

301

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

16.6

376

2380

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

6.7

16.6

WZA00

NOMESCO Finland

Concise certificate

1.7

16.6

294

1747

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

16.5

240

1345

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

16.5

261

1501

SPAT1104

SPAT

Monitoring of emergency patient

1.8

16.5

251

1427

M01AX01

ATC

nabumetone; oral

2.1

16.5

157

762

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

16.5

136

624

F05.9

ICD-10 Finland

Delirium, unspecified

2.6

16.4

354

N02AC04

ATC

dextropropoxyphene; oral

2.2

16.4

134

612

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

16.4

952

7272

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.3

16.4

118

511

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.2

16.4

133

606

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

16.4

154

744

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.3

16.3

120

524

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

16.3

468

3130

R4120, ,

SPAT

3.1

16.3

223

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

16.3

147

699

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.4

16.3

168

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.9

16.2

261

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

6.5

16.2

N05AC02

ATC

thioridazine; oral

2.5

16.2

398

P27

ICPC

Fear of mental disorder

2.9

16.1

262

R15

ICD-10 Finland

Faecal incontinence

2.4

16.1

112

478

S20.2

ICD-10 Finland

Contusion of thorax

1.8

16.1

237

1335

N04AA02

ATC

biperiden; systemic

2.6

16.1

370

R5130, ,

SPAT

6.0

16.0

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

16.0

205

1104

EB1S1

NOMESCO Finland

Photography of teeth

4.3

15.9

-50

ICPC

Medication/prescr/renewal

2.0

15.9

165

827

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

15.9

220

1216

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

4.7

15.8

F48.0

ICD-10 Finland

Neurasthenia

12.2

15.8

F43.00

ICD-10 Finland

Acute stress reaction mild

2.3

15.8

123

551

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

15.8

146

701

GX1K5

NOMESCO Finland

Diffusion capacity

4.1

15.8

102

D01AE15

ATC

terbinafine; topical

1.7

15.8

299

1809

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

15.7

161

803

S02.51

ICD-10 Finland

Fracture of tooth, open

1.6

15.7

402

2621

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.0

15.7

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.9

15.7

120

F30.0

ICD-10 Finland

Hypomania

6.9

15.7

D07AA02

ATC

hydrocortisone; topical

1.5

15.7

607

4317

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.3

15.7

177

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

15.7

1003

7774

H50.52

ICD-10 Finland

Exophoria

3.3

15.7

182

R06AX26

ATC

fexofenadine; oral

1.7

15.6

295

1782

N02CD07, ,

ATC

85.3

15.6

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

15.5

231

1304

N05BA09

ATC

clobazam; oral

19.2

15.5

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

15.5

535

3720

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

15.5

324

S16

ICPC

Bruise/contusion

2.2

15.5

130

601

K07.23

ICD-10 Finland

Deep bite

2.4

15.5

109

468

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

15.4

175

905

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

4.3

15.4

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

15.4

167

850

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

15.4

737

5447

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.9

15.4

201

1090

F22.0

ICD-10 Finland

Delusional disorder

2.9

15.4

247

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.7

15.4

S10

ICPC

Boil/carbuncle

1.7

15.4

261

1532

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.8

15.3

122

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.6

15.3

136

S94

ICPC

Ingrowing nail

2.6

15.3

332

P58

ICPC

Psychological, Therapeutic counselling/listening

2.4

15.3

105

446

G44

ICD-10 Finland

Other headache syndromes

5.9

15.2

P73

ICPC

Affective psychosis

5.0

15.2

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.9

15.2

184

973

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

15.2

349

2217

C09DA01

ATC

losartan and diuretics; oral

1.6

15.2

399

2617

R28

ICPC

Limited function/disability (R)

3.1

15.2

196

A10BH05

ATC

linagliptin; oral

1.9

15.2

192

1031

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

3.6

15.2

137

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.3

15.2

112

491

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

5.3

15.1

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.8

15.1

266

IFA37

NOMESCO Finland

Ketamine treatment

20.1

15.1

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.7

15.1

300

A02BA03

ATC

famotidine; systemic

2.1

15.1

134

634

XF409

NOMESCO Finland

Other special ECG

5.1

15.0

B01AF02

ATC

apixaban; oral

1.5

15.0

510

3534

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

15.0

118

531

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.3

15.0

167

L05

ICPC

Flank/axilla symptom/complaint

1.7

15.0

275

1649

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

15.0

413

JAH01

NOMESCO Finland

Laparoscopy

1.9

15.0

195

1057

315

Kela drug reimbursment

Clopidogrel

4.8

14.9

R03DC01

ATC

zafirlukast; oral

3.0

14.9

219

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

14.9

100

420

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.4

14.9

153

SGC10

NOMESCO Finland

Pulp capping

1.6

14.9

391

2564

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

14.9

158

799

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

14.9

1592

13241

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

14.9

103

439

A85

ICPC

Adverse effect medical agent

3.3

14.9

168

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.2

14.8

SPAT1252

SPAT

Overall medication plan or its review

1.8

14.8

243

1413

XCK00

NOMESCO Finland

Perimetry

1.8

14.8

233

1339

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

14.8

147

726

G03DB01

ATC

dydrogesterone; oral

1.5

14.7

456

3100

IAB01, ,

SPAT

4.3

14.7

C09DA06

ATC

candesartan and diuretics; oral

1.7

14.7

282

1711

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

14.7

390

2563

ZXE00

NOMESCO Finland

One hour or less

1.3

14.7

1694

14217

G04BD11

ATC

fesoterodine; oral

2.3

14.7

112

498

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.7

14.7

126

R07.2

ICD-10 Finland

Precordial pain

2.5

14.7

357

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

5.3

14.6

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.1

14.6

190

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

4.1

14.6

C09CA03

ATC

valsartan; oral

1.6

14.6

360

2327

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.8

14.6

260

S71

ICPC

Herpes simplex

3.7

14.6

122

F43.8

ICD-10 Finland

Other reactions to severe stress

2.1

14.6

136

656

R61.1

ICD-10 Finland

Generalized hyperhidrosis

6.3

14.5

D07AB08

ATC

desonide; topical

1.5

14.5

466

3191

G04CB02

ATC

dutasteride; oral

1.6

14.5

330

2091

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.8

14.5

255

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

14.5

369

2402

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

14.5

176

932

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

14.5

1094

8679

WX892

NOMESCO Finland

Monitored bed care

1.7

14.5

300

1858

XJH10

NOMESCO Finland

Anorectal manometry

6.6

14.5

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.9

14.5

109

J01MA06

ATC

norfloxacin; oral

1.5

14.4

481

3321

SPA47

NOMESCO Finland

Precision impression for denture

2.2

14.4

118

541

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

14.4

174

921

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

14.4

407

2715

N05AD03

ATC

melperone; systemic

3.4

14.3

152

OAB74, ,

SPAT

3.3

14.3

167

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.0

14.3

203

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

14.3

454

3102

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

14.3

164

852

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.7

14.3

274

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

14.3

627

4560

Z2221

NOMESCO Finland

Medical doctor

1.3

14.3

1175

9432

K58

ICD-10 Finland

Irritable bowel syndrome

2.2

14.3

119

549

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

14.2

1536

12773

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.2

14.2

118

543

I20.09

ICD-10 Finland

Unstable angina

1.8

14.2

205

1147

I95.9

ICD-10 Finland

Hypotension, unspecified

2.8

14.2

258

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.7

14.2

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

14.2

158

813

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

14.2

384

2536

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

14.2

413

2772

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

14.2

390

2585

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

14.1

111

500

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.1

14.1

189

G25.0

ICD-10 Finland

Essential tremor

2.2

14.1

113

513

N02CX04, ,

ATC

2.9

14.1

232

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

4.3

14.1

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

4.0

14.0

WYA30, ,

SPAT

4.0

14.0

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

14.0

942

7343

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

14.4

14.0

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.9

14.0

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.9

14.0

107

A10BX01

ATC

guar gum; oral

2.1

14.0

132

639

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

14.0

175

936

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

14.0

387

2567

EEC05

NOMESCO Finland

Le Fort I osteotomy

5.8

14.0

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

5.8

14.0

D17

ICPC

Incontinence of bowel

3.4

14.0

140

S01

ICPC

Pain/tenderness of skin

1.8

13.9

194

1074

J02AC02

ATC

itraconazole; systemic

1.4

13.9

711

5307

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.9

13.9

103

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

10.0

13.9

M75.8

ICD-10 Finland

Other shoulder lesions

1.9

13.9

168

889

SPAT1043

SPAT

Audiometry

1.5

13.9

379

2507

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.2

13.9

112

510

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

13.9

237

1394

A10BB01

ATC

glibenclamide; oral

2.1

13.8

133

649

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

13.8

217

1246

C07AB12

ATC

nebivolol; oral

2.2

13.8

114

524

ZYC01, ,

SPAT

1.5

13.8

489

3416

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.4

13.8

141

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

13.8

124

590

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.0

13.8

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

13.8

294

1835

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

13.7

116

538

OAB44, ,

SPAT

1.5

13.7

463

3205

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

13.7

196

1095

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.7

13.7

258

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.4

13.7

142

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.9

13.6

161

845

P28

ICPC

Limited function/disability (P)

3.4

13.6

147

N05AA01

ATC

chlorpromazine; systemic, rectal

2.9

13.6

225

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2143

11899

2.31

184.30

2.6

2.0

194.07

240.04

u/l

1.08

2039

11219

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4511

34666

2.68

173.06

5.6

4.0

14.63

14.70

pmol/l

1.21

4258

31964

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3214

21575

2.18

167.07

8.5

7.3

1.21

mmol/l

1.73

2825

18728

(3036481) Cortisol [Moles/volume] in Serum or Plasma

945

3752

2.83

163.96

2.3

2.4

361.28

387.87

nmol/l

3.81

883

3473

(3015377) Calcium [Moles/volume] in Serum or Plasma

2433

14843

2.15

159.71

3.1

3.7

2.35

mmol/l

2.09

2274

13610

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4335

33169

2.45

159.37

5.5

4.0

11.13

11.45

mm/h

0.78

4155

31105

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3022

20074

2.12

157.94

3.0

2.4

77.18

76.45

nmol/l

0.70

2848

18417

(3021960) Folate [Moles/volume] in Serum or Plasma

2093

12099

2.18

157.24

1.9

1.6

20.37

19.94

nmol/l

0.58

1878

10392

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2917

19178

2.11

155.96

7.4

6.7

1.21

mmol/l

1.42

2745

17819

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4432

34431

2.48

154.27

9.2

8.3

77.81

78.91

u/l

0.78

4291

32780

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2906

19153

2.10

153.45

2.5

2.0

97.73

94.90

pmol/l

2.53

1676

10326

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2281

13812

2.11

150.19

3.3

2.6

58.40

61.43

u/l

0.46

2137

12868

(3024561) Albumin [Mass/volume] in Serum or Plasma

2943

19674

2.07

147.32

5.4

35.93

35.71

g/l

1.29

2786

18509

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

646

2203

3.19

146.08

4.3

4.4

5.19

5.09

kpa

1.94

624

2107

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1616

8661

2.23

144.44

1.9

1.7

12571837.46

22881665.29

pmol/l

0.59

1400

7351

(3013826) Glucose [Moles/volume] in Serum or Plasma

3593

25963

2.11

144.11

6.2

4.8

6.71

6.66

mmol/l

0.46

3451

24359

(3009343) pH of Capillary blood

629

2130

3.21

143.84

4.3

4.4

7.41

7.42

1.36

552

1785

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2459

15498

2.06

143.51

4.9

3.3

78.48

89.61

ng/l

0.10

1609

10310

(3021601) Nitrite [Presence] in Urine by Test strip

3397

24104

2.07

142.31

4.7

3.5

0.00

estimate

1.34

784

4935

(3009261) Glucose [Presence] in Urine by Test strip

3440

24552

2.07

141.42

4.7

3.6

0.02

estimate

0.05

730

4764

(3035350) Ketones [Presence] in Urine by Test strip

3421

24380

2.07

141.04

4.7

3.5

1.76

4.21

estimate

0.61

789

5021

(3019309) Folate [Moles/volume] in Red Blood Cells

1321

6653

2.30

136.13

1.8

1.7

1227.11

1150.44

nmol/l

2.21

1059

5076

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2422

15470

2.01

133.28

3.8

3.3

31.35

35.40

u/l

0.83

2295

14651

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

566

1882

3.24

133.05

4.1

4.3

1.75

1.85

mmol/l

0.27

404

1361

(3030981) Hyaline casts [#/volume] in Urine by Automated count

859

3589

2.65

132.99

3.2

2.5

0.31

0.47

e6/l

1.18

836

3432

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1972

11761

2.06

130.89

3.6

3.1

1271.07

1514.87

ng/l

1.15

1678

10232

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3175

22419

1.99

129.41

4.1

3.0

107.33

126.38

ug/l

6.97

3024

21126

(3029937) Albumin [Presence] in Urine by Test strip

2119

13035

2.02

128.47

4.5

3.7

0.00

estimate

0.04

725

4533

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3261

23293

1.98

127.89

6.4

6.9

10.91

12.07

umol/l

5.19

3121

22255

(3013115) Eosinophils [#/volume] in Blood

3349

24176

1.99

126.94

7.3

6.7

0.20

0.19

e9/l

1.22

3014

21096

(3032080) INR in Blood by Coagulation assay

2842

19491

1.95

124.23

15.4

13.9

1.23

1.25

inr

1.03

2462

16156

(3022948) Iron [Moles/volume] in Serum or Plasma

1420

7646

2.16

122.29

2.9

2.7

13.84

13.37

umol/l

1.61

1343

7166

(1002224) Polysomnography panel

461

1423

3.44

121.88

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

3305

24028

1.94

119.32

7.2

6.5

1.98

1.91

e9/l

1.08

2996

21150

(3001604) Monocytes [#/volume] in Blood

3242

23422

1.94

119.26

7.1

6.5

0.58

e9/l

0.33

2886

20100

(3006315) Basophils [#/volume] in Blood

3247

23473

1.94

119.18

7.1

6.5

0.04

e9/l

0.30

2891

20154

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1341

7144

2.16

118.13

2.9

2.6

2.38

2.30

g/l

6.09

1260

6637

(3019150) Specific gravity of Urine by Refractometry

1798

10692

2.01

117.66

4.3

3.6

1.02

kg/l

0.81

1295

6983

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2435

16080

1.92

116.91

4.1

3.3

—

1.92

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4928

41787

2.73

116.03

7.1

4.8

1.78

1.89

mu/l

12.30

4685

38823

(3037467) Urinalysis macro (dipstick) panel - Urine

3988

31079

2.03

115.49

5.7

4.2

2.94

2.99

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3834

29567

1.98

113.09

6.2

4.2

543.48

1823.51

e6/l

2.14

225

371

(3015736) pH of Urine

2778

19353

1.88

111.20

4.1

3.2

6.19

6.22

0.65

1666

10778

(3022096) Basophils/Leukocytes in Blood

3011

21555

1.88

110.26

7.3

6.8

0.66

0.68

1.08

2862

20264

(3019069) Monocytes/Leukocytes in Blood

3011

21607

1.87

108.87

7.3

6.8

8.67

8.86

3.58

2866

20348

(3022313) Gas panel - Capillary blood

437

1411

3.28

107.17

4.4

4.8

—

(3018010) Neutrophils/Leukocytes in Blood

3029

21845

1.86

107.06

7.1

6.5

56.97

57.29

0.82

2931

20925

(3018095) Leukocytes [#/volume] in Urine

2504

17023

1.86

106.85

5.3

3.8

69.34

88.74

e6/l

0.91

1917

11746

(3002030) Lymphocytes/Leukocytes in Blood

3071

22254

1.86

106.79

7.3

6.7

28.41

27.89

1.85

2954

21143

(3006504) Eosinophils/Leukocytes in Blood

2997

21569

1.86

106.37

7.2

6.7

2.87

2.83

0.55

2848

20291

(3015235) Bicarbonate [Moles/volume] in Capillary blood

386

1159

3.51

106.23

3.9

3.3

24.83

24.67

mmol/l

0.29

378

1139

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2635

18224

1.86

106.23

4.6

3.4

0.02

0.18

estimate

0.71

593

4095

(3018418) pH of Serum or Plasma

2019

12860

1.90

105.28

4.6

4.4

7.40

1.08

1507

9011

(3002582) Erythrocytes [#/volume] in Urine

2225

14684

1.87

103.33

4.2

3.3

64.97

90.05

e6/l

0.40

1815

11073

(3041096) Erythrocytes [Presence] in Urine by Automated

2046

13160

1.88

102.94

4.1

3.0

0.49

0.13

estimate

0.40

588

3892

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1731

10587

1.93

101.32

1.4

1.3

1.47

2.15

u/ml

1.35

569

2934

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1214

6588

2.08

99.73

2.9

2.7

23.38

0.00

1142

6154

(3037522) Nuclear Ab [Titer] in Serum

1164

6222

2.10

99.53

1.5

1.4

423.93

514.98

titre

1.19

214

1307

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1119

5913

2.12

98.52

2.1

1.7

1.47

1.45

0.73

1030

5254

(3013650) Neutrophils [#/volume] in Blood by Automated count

3461

26400

1.84

98.12

9.9

10.2

4.13

4.12

e9/l

0.07

3104

22858

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1862

11764

1.88

97.96

2.6

2.2

2.86

2.73

mg/l

1.43

1666

10199

(3000850) Epithelial cells [#/volume] in Urine

1630

9940

1.91

95.13

3.4

2.6

5.56

5.48

e6/l

0.08

1494

9011

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3953

31753

1.87

91.09

4.2

3.1

47.84

45.41

u/l

0.95

3777

30011

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1553

9436

1.90

90.92

1.9

1.7

0.92

1.31

mg/l

6.86

1178

7305

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1374

8040

1.95

89.99

1.4

1.3

20.20

34.68

iu/ml

3.97

365

2455

(3026782) Osmolality of Urine

1427

8500

1.92

88.36

3.6

2.9

541.30

543.37

mosm/kgh2o

0.12

1266

7439

(40768797) Stomach Pathology biopsy report

1070

5769

2.06

88.25

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1086

5900

2.05

87.66

2.3

2.6

116.04

134.84

ug/g

1.02

874

4752

(3009508) Creatinine [Moles/volume] in Urine

2206

15095

1.77

86.54

3.8

3.4

7.78

7.76

mmol/l

0.07

1934

12979

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4939

43310

2.38

83.56

6.1

4.6

5.98

5.86

mmol/l

8.88

4675

40093

(3044889) 12 lead EKG panel

3860

31197

1.80

82.03

4.7

3.7

0.20

6867.57

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1253

7354

1.91

80.02

1.4

1.3

12.83

11.78

u/ml

0.09

507

2900

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1235

7258

1.90

78.33

3.3

3.6

0.82

mmol/l

1.58

1141

6869

(3019550) Sodium [Moles/volume] in Serum or Plasma

5127

46100

2.67

75.33

25.1

16.4

139.67

mmol/l

0.06

5076

45102

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4828

42379

2.14

74.25

8.1

5.6

39.93

38.62

mmol/mol

14.36

4603

39852

(3009466) Valproate [Moles/volume] in Serum or Plasma

180

403

4.58

74.18

6.6

6.4

376.87

371.17

umol/l

0.18

164

342

(3028707) Methadone [Presence] in Urine by Screen method

284

884

3.33

73.48

3.0

2.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5126

46223

2.61

72.33

25.4

16.6

3.97

mmol/l

0.54

5068

45124

(3026008) Bacteria identified in Urine by Culture

1861

12636

1.71

71.53

3.7

2.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

285

907

3.26

71.11

4.3

3.1

24.83

27.42

mg/l

0.56

222

622

(3026493) Urate [Moles/volume] in Serum or Plasma

1733

11578

1.73

70.42

2.9

2.7

350.49

340.63

umol/l

3.42

1551

10378

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5075

45687

2.44

69.50

22.2

14.3

20.95

25.30

mg/l

20.51

4476

36908

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1004

5710

1.93

69.38

6.6

6.7

1.04

mmol/l

0.13

935

5341

(40760892) CBC W Ordered Manual Differential panel - Blood

1604

10538

1.74

68.95

5.0

4.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1455

9332

1.76

67.91

1.6

1.5

2.39

2.43

g/l

0.27

951

5902

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

261

810

3.33

67.81

1.2

1.3

3.59

3.72

mmol/l

1.45

255

767

(3040151) Glucose [Moles/volume] in Capillary blood

179

429

4.28

67.63

48.2

5.3

7.79

7.16

mmol/l

1.29

150

366

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

282

932

3.14

66.02

1.2

1.3

453.13

555.38

mg/l

2.98

268

891

(3028626) Oxygen [Partial pressure] in Capillary blood

294

1022

2.98

63.02

4.5

3.8

8.37

8.23

kpa

0.74

289

997

(3021589) Normoblasts [#/volume] in Blood

2717

20798

1.61

62.56

13.4

10.9

0.00

e9/l

2.00

2296

16891

(44816559) Phosphatidylethanol [Mass/volume] in Blood

455

1991

2.40

61.64

1.8

0.26

0.32

mg/l

1.28

171

979

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

250

807

3.20

60.86

1.3

1.4

2689.61

5474.67

e6/l

0.22

213

625

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

555

2658

2.21

60.79

3.6

3.5

4.49

4.52

pmol/l

0.39

500

2390

(3020682) Albumin/Creatinine [Ratio] in Urine

1957

13959

1.62

59.49

4.7

4.1

9.34

9.11

mg/mmol

0.07

1326

8887

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

246

798

3.18

59.39

1.2

1.4

27.24

33.73

e6/l

0.14

196

583

(3023368) Bacteria identified in Blood by Culture

1752

12168

1.65

59.23

4.8

4.4

—

(3021440) Promyelocytes/Leukocytes in Blood

719

3845

2.00

58.70

4.4

4.7

0.08

0.11

0.72

189

1029

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

591

2944

2.13

58.49

2.4

27.16

20.86

au/ml

0.69

357

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1299

8367

1.72

58.32

2.8

3.2

2.43

2.45

mmol/l

3.59

1177

7515

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1014

6090

1.82

57.96

2.0

2.2

29.49

29.80

1.01

983

5914

(3017181) Myelocytes/Leukocytes in Blood

742

4032

1.97

57.81

4.3

4.6

0.80

0.96

0.83

212

1210

(3015171) Extractable nuclear Ab [Units/volume] in Serum

391

1657

2.46

56.74

1.3

1.2

0.64

1.34

u/ml

1.03

136

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

302

1130

2.77

56.46

4.7

5.0

24.66

24.61

mmol/l

0.12

283

1037

(3025159) Blasts/Leukocytes in Blood

721

3910

1.97

56.41

4.5

4.8

0.02

0.33

1.86

188

990

(40758558) Short blood count panel - Blood

1932

13969

1.59

54.23

6.9

6.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

554

2776

2.11

53.80

1.5

1.3

378.06

278.61

u/ml

0.23

522

2581

(3000570) Elastase.pancreatic [Mass/mass] in Stool

311

1220

2.64

52.96

1.5

1.4

304.57

268.74

ug/g

2.20

197

736

(3012516) Albumin [Mass/volume] in Urine

1892

13709

1.58

52.11

3.9

3.5

44.19

50.89

mg/l

0.66

1299

8867

(3022145) Colonoscopy Study observation

855

5042

1.82

51.33

1.3

1.4

—

(3003396) Base excess in Arterial blood by calculation

836

4928

1.82

50.16

7.0

8.0

1.40

0.78

mmol/l

4.87

697

4034

(3008152) Bicarbonate [Moles/volume] in Arterial blood

509

2559

2.09

48.82

6.3

6.7

24.69

24.34

mmol/l

1.30

493

2440

(3016502) Oxygen saturation in Arterial blood

770

4466

1.84

48.59

7.2

8.3

94.55

95.68

3.36

746

4308

(3030467) Casts [#/volume] in Urine by Automated count

1763

12744

1.56

48.17

3.9

3.2

0.35

0.43

e6/l

1.22

1347

9204

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4428

39188

1.67

47.47

26.3

17.8

13.63

13.55

3.82

4394

38629

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

526

2718

2.03

46.77

1.3

46.89

55.45

au/ml

0.31

205

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

575

3079

1.97

46.19

1.5

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

351

1554

2.34

46.03

3.1

2.6

—

(3019977) pH of Arterial blood

825

4963

1.78

45.93

7.1

8.0

7.41

7.42

0.51

509

2566

(3021387) Prolactin [Units/volume] in Serum or Plasma

386

1784

2.25

45.75

1.7

325.77

297.23

mu/l

0.66

352

1605

(1001926) Buprenorphine [Presence] in Urine by Screen method

382

1763

2.25

45.43

2.8

2.0

—

(3002179) Metamyelocytes/Leukocytes in Blood

677

3852

1.86

45.21

3.9

4.5

0.58

0.72

0.79

188

1157

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4825

43869

1.82

45.09

20.3

14.0

83.65

83.49

ml/min/173m2

0.19

4527

40190

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

572

3117

1.93

43.54

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1118

7403

1.64

43.44

3.6

3.1

3.00

2.30

e6/l

1.30

634

3589

(1616796) Gas panel - Central venous blood

227

840

2.78

43.28

3.5

3.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

361

1664

2.25

43.02

1.9

1.7

3.34

4.04

mg/l

0.84

321

1152

(3006184) Hemoglobin [Mass/volume] in Capillary blood

244

944

2.66

42.66

2.1

2.3

135.49

129.24

g/l

3.49

208

735

(3005719) IgG [Mass/volume] in Serum or Plasma

614

3451

1.88

42.48

2.5

3.0

10.12

10.63

g/l

2.61

567

3212

(3007853) Bacteria identified in Skin by Aerobe culture

841

5195

1.73

42.40

2.0

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

132

362

3.71

41.44

3.2

70.91

32.05

mg/l

0.87

275

(3024666) Lithium [Moles/volume] in Serum or Plasma

109

261

4.24

41.28

12.3

14.4

0.61

0.63

mmol/l

0.41

240

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

807

4984

1.73

40.58

7.3

8.0

5.19

5.07

kpa

3.09

775

4792

(3027801) Oxygen [Partial pressure] in Arterial blood

806

4981

1.72

40.42

7.3

8.0

11.55

12.71

kpa

8.54

775

4791

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1198

8193

1.59

40.37

4.6

3.6

225.54

521.31

ng/l

2.12

862

6333

(3002173) Hemoglobin [Mass/volume] in Arterial blood

704

4194

1.78

40.15

7.6

8.8

124.11

120.99

g/l

3.47

694

4089

(36304419) Bacteria [Presence] in Urine

1651

12155

1.51

39.78

3.7

3.1

1.42

343.67

estimate

0.62

(3000494) Fungus identified in Specimen by Culture

854

5395

1.69

39.42

1.6

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5215

49017

2.25

39.19

27.4

18.2

80.18

77.53

umol/l

4.84

5184

48414

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5193

48782

2.17

38.20

14.9

11.1

27.79

26.20

u/l

1.77

5116

47433

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

202

4.56

37.97

1.1

1.86

9.44

nmol/l

1.97

(3017446) Testosterone [Moles/volume] in Serum or Plasma

707

4288

1.74

37.74

2.9

2.0

12.20

13.55

nmol/l

4.38

641

3885

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4684

42710

1.65

37.25

4.9

3.9

1.38

1.25

mmol/l

24.97

4434

39720

(3014051) Protein [Presence] in Urine by Test strip

1765

13333

1.48

36.84

3.5

2.8

0.03

0.05

0.40

294

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

548

3116

1.84

36.30

4.2

4.3

92.87

90.86

ng/l

0.21

484

2733

(3013139) Helicobacter pylori Ag [Presence] in Stool

529

2983

1.86

35.97

1.2

—

(3016879) Cocaine [Presence] in Urine

410

2124

2.01

35.93

2.7

2.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

806

5140

1.67

35.60

2.9

2.7

1.77

1.75

0.30

741

4615

(3009214) Lutropin [Units/volume] in Serum or Plasma

297

1369

2.24

35.32

1.4

9.30

10.16

u/l

0.54

239

1090

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4952

45972

1.78

35.09

6.5

5.1

2.67

2.75

mmol/l

9.02

4727

43130

(3025941) Bacteria identified in Stool by Culture

447

2412

1.93

34.78

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

426

2297

1.93

33.18

2.6

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

423

2279

1.93

33.02

2.7

1.9

—

(3028300) Cannabinoids [Presence] in Urine

426

2302

1.92

32.96

2.7

1.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

278

1283

2.23

32.95

1.3

15.17

30.55

u/ml

0.57

(3023323) Follitropin [Units/volume] in Serum or Plasma

439

2399

1.90

32.83

1.5

1.4

21.53

26.42

iu/l

2.54

365

2028

(3020779) Urea [Moles/volume] in Serum or Plasma

667

4145

1.69

32.30

8.6

7.8

9.72

9.87

mmol/l

0.19

639

3988

(3042936) Bacteria identified in Isolate by Culture

950

6465

1.57

31.81

2.2

2.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

102

282

3.67

31.71

1.9

2.4

20.01

19.20

nmol/l

0.32

267

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

106

302

3.56

31.51

1.1

236.07

274.68

mg/l

1.23

266

(3003327) Ova and parasites identified in Stool by Light microscopy

321

1602

2.07

31.12

1.9

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

219

938

2.39

30.90

2.7

2.4

77.95

88.73

ug/min

0.15

148

567

(3027944) Amphetamines [Presence] in Urine

415

2271

1.89

30.86

2.7

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4878

45366

1.67

30.86

5.9

4.6

4.53

4.65

mmol/l

15.62

4664

42727

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1023

7126

1.54

30.73

2.2

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4855

45111

1.65

30.66

5.7

4.5

1.39

1.46

mmol/l

11.44

4623

42263

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

107

315

3.44

30.27

1.2

1.1

38.65

44.65

mg/l

0.49

261

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

128

5.05

30.27

1.9

3.1

9.73

10.27

kpa

0.41

128

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

128

5.05

30.27

1.9

3.1

5.12

4.90

kpa

0.70

128

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

531

3159

1.75

30.01

1.4

1.2

80.40

154.23

u/ml

5.79

197

1169

(3044242) Glucose [Moles/volume] in Arterial blood

233

3.87

29.94

2.0

8.96

8.06

mmol/l

0.97

233

(3021447) Carbon dioxide [Partial pressure] in Venous blood

701

4499

1.64

29.84

4.6

4.0

5.95

5.78

kpa

4.55

676

4384

(3020961) Endomysium IgA Ab [Titer] in Serum

400

2191

1.89

29.64

1.2

1.1

251.54

150.28

titre

0.21

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

243

1113

2.24

29.33

2.4

1.8

193.84

212.52

pmol/l

1.98

229

1049

(3044640) Blood type and Crossmatch panel - Blood

1901

15061

1.40

28.82

2.4

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2617

21858

1.38

28.79

2.9

2.8

—

estimate

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

7.10

28.79

1.9

2.3

14.70

16.86

umol/l

0.62

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

218

963

2.32

28.68

1.3

1.2

23.82

39.48

u/ml

1.15

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

255

1203

2.17

28.62

1.3

3.36

3.23

u/ml

0.03

109

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1234

9051

1.47

28.58

1.8

1.6

—

(3002032) Base excess in Venous blood by calculation

682

4399

1.63

28.37

4.7

4.1

1.99

1.61

mmol/l

1.88

600

3788

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

9.24

28.25

2.9

2.5

24.58

24.90

umol/l

0.04

(3012544) pH of Venous blood

704

4586

1.61

28.11

4.6

4.0

7.38

0.11

412

2648

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

253

1202

2.16

27.89

1.3

8.54

6.71

u/ml

0.13

178

(3024354) Oxygen [Partial pressure] in Venous blood

595

3728

1.67

27.72

4.0

3.4

4.70

4.56

kpa

0.84

574

3629

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

787

5284

1.57

27.62

2.1

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

534

3254

1.71

27.61

4.2

4.1

1.22

1.23

mmol/l

0.08

466

2806

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

430

2469

1.80

27.36

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2284

18776

1.37

27.20

2.1

1.8

1.46

1.32

mmol/l

8.29

1981

16126

(3032773) Endomysium IgG Ab [Titer] in Serum

128

453

2.87

26.60

1.2

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

227

3.70

26.27

1.3

1.2

0.50

0.67

ratio

2.53

125

(3045414) Leukocytes [Presence] in Urine

645

4180

1.62

26.21

2.1

2.0

0.00

0.02

estimate

1.71

206

888

(3028026) IgM [Mass/volume] in Serum or Plasma

457

2710

1.75

26.01

1.9

2.1

1.12

1.38

g/l

2.99

418

2511

(3023183) Ammonium ion [Moles/volume] in Plasma

206

927

2.27

25.96

2.7

2.8

31.19

34.44

umol/l

1.11

188

843

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

785

5341

1.55

25.85

2.7

2.9

6.73

8.98

umol/l

3.31

656

4724

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3442

30301

1.36

25.76

3.5

3.1

—

(3012501) Base excess in Blood by calculation

177

752

2.40

25.46

4.8

4.0

2.52

2.65

mmol/l

0.23

126

485

(3018405) Lactate [Moles/volume] in Arterial blood

265

1330

2.04

25.29

3.3

4.0

1.42

mmol/l

0.02

258

1305

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

741

5012

1.55

25.00

2.1

1.8

—

(40768804) Tissue Pathology biopsy report

2219

18330

1.35

24.90

2.2

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

390

2239

1.80

24.79

1.8

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

329

1799

1.88

24.46

1.9

1.8

5.44

7.60

iu/ml

0.95

422

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

285

3.27

24.08

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

337

1867

1.86

24.04

2.4

1.9

40.23

40.25

u/l

0.00

310

1670

(3045424) Erythrocytes [Presence] in Urine

366

2084

1.81

23.89

2.2

2.1

0.00

0.02

estimate

0.92

159

677

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

305

3.15

23.46

1.4

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

145

588

2.51

23.10

1.3

—

(4198724) Urine methamphetamine measurement

222

3.50

22.58

2.6

2.3

—

(3042517) Benzodiazepines panel - Urine

7.79

22.52

3.9

3.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

493

3109

1.64

22.22

3.1

2.8

177.44

202.85

ng/l

0.48

434

2836

(3008898) HLA-B27 [Presence]

296

1616

1.88

22.11

1.1

—

(36660697) Celiac disease serology panel - Serum

563

3682

1.59

21.85

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

639

4309

1.55

21.68

3.8

3.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

609

4064

1.56

21.65

7.3

8.0

1.36

1.32

mmol/l

0.32

591

3985

(3011397) Hemoglobin [Presence] in Urine by Test strip

1414

11087

1.37

21.42

4.3

3.5

0.00

0.13

—

118

(3023410) Appearance of Cerebral spinal fluid

103

366

2.85

21.32

1.4

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

310

1742

1.83

21.12

2.0

1.9

1.28

2.71

ug/l

2.25

274

1548

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

224

1140

2.01

20.59

1.2

—

(3017732) Neutrophils [#/volume] in Blood

798

5698

1.47

20.49

3.6

3.3

4.62

4.58

e9/l

0.05

722

4978

(3014765) Yersinia sp identified in Stool by Organism specific culture

224

1143

2.00

20.44

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

546

3602

1.57

20.36

2.3

2.7

66.38

66.30

g/l

0.08

497

3323

(3004119) Hemoglobin [Mass/volume] in Venous blood

435

2718

1.65

20.30

3.7

3.3

129.96

129.17

g/l

0.33

419

2648

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

243

1281

1.94

20.19

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

162

737

2.23

19.95

2.1

1.9

5.18

4.96

mmol/24h

0.35

145

654

(42529406) Shigella sp [Presence] in Stool by Culture

223

1149

1.98

19.80

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

249

1340

1.90

19.45

1.4

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

245

1312

1.91

19.43

1.9

1.7

0.23

g/l

0.06

234

1251

(3027273) Bicarbonate [Moles/volume] in Venous blood

323

1885

1.76

19.38

4.5

3.4

25.40

25.03

mmol/l

1.21

308

1813

(3033658) Prothrombin time (PT) actual/Normal

1449

11556

1.34

19.31

4.3

4.2

90.63

89.40

1.10

1408

11321

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

250

1360

1.88

18.89

2.0

1.7

1.21

1.16

g/l

1.93

238

1301

(3000991) Gas panel - Venous blood

580

3954

1.52

18.59

8.7

9.4

—

(3020891) Body temperature

321

1901

1.73

18.29

4.4

4.5

36.92

36.90

°c

0.47

321

1883

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

237

1283

1.89

18.19

1.4

1.3

—

(44813793) Dust mix specific IgE antibody measurement

293

2.90

18.04

1.0

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1049

8033

1.38

17.96

3.4

2.9

1.20

1.08

e6/l

0.32

570

4226

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

283

1627

1.78

17.88

1.7

9.73

15.71

u/ml

1.77

450

(46235355) HIV 1 and 2 tests - Meaningful Use set

1296

10279

1.34

17.65

2.3

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

317

1891

1.72

17.60

5.5

4.6

1.73

1.61

0.92

305

1775

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

348

2131

1.68

17.53

5.2

4.0

52.00

46.51

3.99

343

2096

(3022621) pH of Urine by Test strip

530

3591

1.53

17.45

2.8

2.5

6.11

6.09

0.13

380

2417

(3013005) Retinol [Moles/volume] in Serum or Plasma

195

3.31

17.30

1.6

1.9

2.03

1.90

umol/l

0.54

177

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

192

991

1.97

17.00

1.3

1.24

4.80

u/ml

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

493

3312

1.54

16.87

2.6

2.2

5.70

8.62

ug/l

4.18

413

2947

(3020911) Cortisol [Moles/time] in 24 hour Urine

127

3.88

16.85

1.4

78.01

259.33

nmol/24h

1.43

127

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

625

4411

1.47

16.85

3.0

2.5

58.17

49.04

u/l

0.15

532

3756

(3011985) Renin [Units/volume] in Plasma

125

556

2.28

16.31

1.6

1.5

52.47

58.56

mu/l

0.17

115

489

(3023419) Bacteria identified in Sputum by Culture

113

483

2.37

16.17

3.2

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

212

1152

1.87

16.11

1.2

1.1

3.48

4.38

0.80

172

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

365

2.57

15.98

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

169

856

2.01

15.81

1.7

—

(3007461) Platelets [#/volume] in Blood

5251

50846

1.73

15.74

33.4

21.7

250.99

250.87

e9/l

0.05

5189

49760

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

791

5898

1.40

15.71

2.4

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

415

2726

1.57

15.69

4.9

4.4

24.64

24.01

mmol/l

3.48

406

2700

(3047181) Lactate [Moles/volume] in Blood

220

1221

1.84

15.65

6.2

5.3

1.32

1.26

mmol/l

0.51

199

1065

(1761482) Bacteria [#/volume] in Urine by Culture

191

1013

1.92

15.64

4.4

3.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

610

4346

1.45

15.61

2.2

2.4

0.21

g/l

1.02

556

4053

(3035941) MCH [Entitic mass]

5251

50855

1.73

15.61

33.1

21.6

30.30

30.33

0.59

5222

50323

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5251

50856

1.73

15.59

33.2

21.7

90.84

90.93

0.81

5222

50322

(3010813) Leukocytes [#/volume] in Blood

5252

50872

1.73

15.54

33.4

21.7

6.89

6.71

e9/l

5.27

5180

49620

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5251

50861

1.72

15.52

33.8

22.2

41.39

41.06

0.18

5222

50296

(3026361) Erythrocytes [#/volume] in Blood

5251

50862

1.72

15.50

33.3

21.7

4.53

4.51

e12/l

2.70

5177

49630

(3000963) Hemoglobin [Mass/volume] in Blood

5251

50872

1.72

15.35

33.5

21.9

136.39

135.83

g/l

2.04

5222

50339

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

248

1445

1.75

14.99

2.0

2.4

714.74

656.77

ug/l

0.08

229

1373

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1906

16197

1.27

14.99

5.7

5.4

2.18

3.02

ug/l

3.63

1742

14749

(3003181) Sodium [Moles/volume] in Urine

143

696

2.08

14.94

1.3

1.4

60.59

65.20

mmol/l

0.65

115

548

(3009445) Proteinase 3 Ab [Units/volume] in Serum

302

1860

1.66

14.89

1.4

1.7

8.03

13.93

iu/ml

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

121

553

2.21

14.83

1.3

0.13

0.25

nmol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

278

1680

1.69

14.73

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

205

3.05

14.70

1.1

1.0

1.19

1.13

u/l

0.18

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

265

1582

1.71

14.69

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

400

2645

1.55

14.68

8.9

10.2

24.61

24.15

mmol/l

2.02

385

2597

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

3.22

14.59

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

209

1169

1.82

14.52

1.1

2.30

7.66

eliau/ml

2.66

172

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

846

6456

1.37

14.51

2.5

2.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

395

2.43

14.49

1.2

—

36.20

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

283

1739

1.66

14.09

5.8

4.8

0.86

0.88

0.46

273

1629

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

116

534

2.20

14.00

1.3

7.74

3.93

nmol/l

0.20

111

514

(3023511) Choriogonadotropin [Units/volume] in Urine

184

1001

1.87

13.98

1.5

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

149

755

2.00

13.97

1.2

1.3

85.36

350.33

titre

2.27

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

168

891

1.91

13.80

2.3

1.8

0.88

0.80

nmol/l

0.78

142

765

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

334

2.51

13.60

1.4

1.2

108.07

106.47

pmol/l

0.14

334

(1761868) Lipid panel - Serum or Plasma

2167

18859

1.25

13.44

3.8

2.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

241

1439

1.71

13.38

2.9

2.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

319

2.53

13.37

1.5

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

186

1031

1.83

13.33

1.2

1.3

243.00

253.02

u/ml

0.22

128

642

(3017143) Hepatitis C virus Ab [Presence] in Serum

792

6057

1.36

13.32

1.9

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

333

2.48

13.19

1.4

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

221

2.83

12.91

1.2

1.5

6.22

6.72

u/l

0.17

195

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

322

2089

1.58

12.86

2.4

2.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

273

2.62

12.79

1.0

797.69

717.59

ng/l

0.60

185

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

169

3.10

12.74

1.2

61.17

68.96

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

150

789

1.93

12.66

1.6

1.5

0.38

0.39

nmol/l

0.03

123

628

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

191

2.95

12.63

1.4

1.9

27.99

28.56

umol/l

0.15

175

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

275

2.60

12.61

1.0

39.01

42.79

ng/l

0.41

195

(3047007) Chlamydophila sp Ab [Presence] in Serum

127

631

2.04

12.61

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

100

453

2.23

12.59

1.3

—

nmol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

273

2.58

12.28

1.0

309.50

323.52

ng/l

0.16

193

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

107

505

2.14

12.18

2.0

1.6

395.08

335.00

mu/l

0.56

403

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

190

2.91

12.15

2.3

1.5

88.62

147.62

umol/l

1.11

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

317

2077

1.56

12.13

2.6

2.3

2096.20

6351.06

u/l

3.37

107

848

(40761536) Microorganisms panel - Urine sediment

494

3561

1.43

11.78

4.5

3.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

216

2.75

11.73

1.3

1.4

1.08

1.15

nmol/l

0.24

159

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

526

3838

1.41

11.71

2.7

2.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

464

2.15

11.50

1.3

0.18

0.23

nmol/l

0.72

365

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

114

3.44

11.36

1.6

1.3

135.33

133.08

nmol/l

0.02

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

447

3193

1.44

11.21

2.5

2.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.73

11.17

1.2

1.8

—

0.99

—

(4094501) Cardiovascular stress test using bicycle ergometer

192

1135

1.72

11.11

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

180

1048

1.74

11.00

1.4

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

236

2.60

10.92

1.3

1.4

6.05

8.31

ug/l

0.92

213

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

3.06

10.86

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

515

2.06

10.86

1.4

1.3

328.18

308.65

pmol/l

0.20

430

(4024509) Urine culture

299

1984

1.54

10.83

2.0

1.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

263

2.49

10.62

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

196

1180

1.69

10.62

2.1

2.0

10.59

11.62

mg/l

1.16

185

1112

(3020191) Ethanol [Moles/volume] in Serum or Plasma

350

2.28

10.55

1.9

1.3

1.77

1.32

promille

2.01

276

(3023520) Reticulocytes [#/volume] in Blood

524

3892

1.38

10.49

2.5

2.7

72.98

67.65

e9/l

2.13

393

2827

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

265

2.47

10.46

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

122

642

1.92

10.36

1.4

1.3

18.88

26.55

u/l

2.29

546

(3024263) Appearance of Synovial fluid

214

2.63

10.29

2.0

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

207

1276

1.65

10.26

1.8

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

230

1458

1.60

10.18

3.3

3.8

1.57

1.47

mg/l

0.93

213

1349

(4062490) Immunoglobulin typing, IgG

447

2.10

10.17

1.4

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

303

2.33

9.89

1.2

1.3

2.23

3.33

u/ml

0.28

172

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

364

2564

1.45

9.85

9.2

10.3

16.22

15.99

0.81

353

2463

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

116

612

1.91

9.80

1.1

2.62

3.32

0.32

109

(40761535) Cells panel - Urine sediment

435

3175

1.40

9.66

3.9

3.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

164

970

1.71

9.52

1.4

1.5

127.61

151.60

au/ml

0.88

292

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

686

5384

1.31

9.50

3.1

4.8

235.14

244.52

u/l

0.98

648

5137

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

259

2.41

9.50

1.3

1.2

4.70

5.44

umol/l

0.68

236

(3049717) Cytology report of Urine Cyto stain

245

1605

1.55

9.44

2.6

2.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

116

625

1.87

9.22

1.3

1.4

6.99

7.12

mmol/l

0.19

111

562

(3039162) Centromere protein B Ab [Units/volume] in Serum

103

535

1.94

9.14

1.4

1.3

65.23

42.54

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

364

2603

1.43

9.09

1.9

1.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

454

2.02

9.06

1.4

2.90

2.97

g/l

0.16

331

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

317

2.22

8.94

1.0

1.1

6.35

8.79

iu/ml

0.62

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

138

792

1.76

8.94

1.1

11.13

16.47

au/ml

0.97

213

(3039000) Anion gap in Blood by calculation

142

823

1.74

8.89

7.6

6.3

10.91

11.42

mmol/l

1.27

133

722

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

195

2.58

8.87

1.6

2.36

8.31

nmol/l

1.10

153

(3018572) Chloride [Moles/volume] in Blood

142

824

1.74

8.86

7.7

6.3

105.71

104.98

mmol/l

1.19

133

723

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

216

1396

1.57

8.85

2.9

3.1

0.36

0.32

iu/ml

0.55

109

719

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1760

1.51

8.82

1.8

2.4

4.37

4.15

g/l

2.83

228

1629

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1504

13029

1.21

8.80

5.4

4.4

22.23

21.99

0.23

681

6454

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1761

1.51

8.79

1.8

2.4

7.38

7.35

g/l

0.11

228

1628

(3008295) Osmolality of Serum or Plasma

432

2.03

8.78

1.6

1.4

288.41

279.96

mosm/kgh2o

2.70

334

(3017569) Oxygen content in Arterial blood

220

2.47

8.76

2.3

16.39

16.31

0.05

220

(3024139) IgG subclass 3 [Mass/volume] in Serum

453

2.00

8.75

1.4

0.40

0.42

g/l

0.14

327

(3034860) Kappa light chains.free [Mass/volume] in Serum

219

1424

1.56

8.75

2.4

3.9

47.14

93.13

mg/l

0.65

176

1225

(3027135) IgG subclass 1 [Mass/volume] in Serum

454

2.00

8.70

1.4

6.12

6.87

g/l

2.06

329

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

1758

1.50

8.68

1.8

2.4

3.92

3.76

g/l

0.58

227

1625

(3002256) Pathology report gross observation

774

6244

1.28

8.66

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

191

1209

1.60

8.56

2.5

3.1

2.23

2.06

index

0.07

109

624

(3004716) Salmonella sp identified in Stool by Organism specific culture

330

2344

1.43

8.56

1.3

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

218

1424

1.55

8.54

2.4

3.9

36.18

59.72

mg/l

1.32

174

1228

(3024928) Oxygen saturation in Venous blood

185

1164

1.61

8.51

3.0

3.3

62.63

62.07

0.12

175

1134

(3004616) Nuclear Ab [Presence] in Serum

514

1.92

8.48

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

183

2.58

8.39

3.6

3.3

0.78

1.33

1.97

183

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

219

1438

1.54

8.39

2.1

1.9

—

(40768443) Skin Pathology biopsy report

278

1929

1.46

8.17

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

127

733

1.75

8.11

3.1

3.8

1.40

1.66

0.41

120

644

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

244

1657

1.49

8.00

1.8

2.5

2.86

2.95

g/l

0.78

211

1526

(3036489) Thrombin time

234

1580

1.50

7.89

1.9

2.3

20.26

21.26

1.80

204

1402

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

117

2.92

7.68

1.2

1.3

—

(21494755) Public health laboratory ask at order entry panel

381

5061

0.73

7.66

1.3

—

(3019225) pH of Specimen

494

3818

1.32

7.62

5.2

4.3

7.36

0.07

372

2748

(3003329) Lymphocytes/Leukocytes in Synovial fluid

354

2.05

7.53

1.5

32.54

30.74

0.14

220

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

294

2098

1.42

7.47

1.5

1.8

1.48

1.50

g/l

0.18

251

1833

(3000475) Leukocytes [#/volume] in Synovial fluid

166

1052

1.60

7.46

1.7

1.6

13708.45

13864.87

e6/l

0.02

125

726

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

195

1284

1.54

7.42

2.3

3.7

1.31

2.98

ratio

3.55

112

736

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

114

2.91

7.41

2.2

1.7

62.99

144.14

au/ml

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

124

732

1.71

7.35

1.1

100.23

14735.12

iu/ml

0.53

159

(3037756) Immunofixation for Serum or Plasma

142

871

1.65

7.29

1.5

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

326

4399

0.72

7.25

1.6

3.44

3.49

mmol/l

0.35

226

2961

(3038177) Helicobacter pylori Ab [Presence] in Serum

127

759

1.69

7.20

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.68

7.17

1.1

0.58

0.71

umol/24h

0.55

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

156

2.58

7.17

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

146

2.61

7.02

1.2

1.3

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4198

40141

1.19

7.01

27.2

18.2

332.82

332.78

g/l

0.10

4183

39901

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1334

1.51

6.99

1.7

2.3

0.01

0.03

g/l

1.14

168

1204

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

351

2.01

6.97

1.9

2.1

13.06

15.04

0.97

341

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

462

5884

0.77

6.89

1.8

1.9

3.50

3.46

ratio

0.32

357

4444

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

225

1553

1.47

6.85

2.0

2.4

0.54

0.90

g/l

1.50

183

1344

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.11

6.85

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

114

2.82

6.83

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

1533

1.47

6.75

1.8

2.5

9.65

10.25

g/l

1.61

186

1386

(3008757) Leukocyte morphology finding [Identifier] in Blood

404

1.92

6.74

3.2

4.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.26

6.74

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

161

2.50

6.74

2.3

8.64

10.09

mg/l

1.03

141

(3024980) IgG subclass 4 [Mass/volume] in Serum

129

790

1.65

6.70

1.4

1.6

0.65

0.83

g/l

1.65

100

630

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

350

1.98

6.67

1.9

2.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

168

2.45

6.66

1.6

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

8.68

6.54

1.7

1.5

541.65

601.63

nmol/l

0.08

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

167

1095

1.54

6.52

1.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

992

1.57

6.51

1.6

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

179

1193

1.52

6.49

1.7

2.1

2.37

4.16

iu/l

5.22

503

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.98

6.37

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

573

1.74

6.35

1.1

1.2

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.94

6.29

1.8

1.6

2.41

1.56

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.94

6.29

1.8

1.6

1.56

0.68

mg/l

1.22

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.94

6.29

1.8

1.6

1.28

3.01

mg/l

0.88

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.94

6.29

1.8

1.6

2.67

2.88

mg/l

0.06

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.94

6.25

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.73

6.13

1.8

1.6

2.06

1.37

mg/l

0.19

(3020876) Protein [Mass/time] in 24 hour Urine

560

1.73

6.01

2.2

2.5

1.36

1.18

g/24h

0.24

335

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

118

728

1.63

5.99

1.8

1.7

—

(3035715) Granulocytes [#/volume] in Blood

125

785

1.61

5.92

3.3

3.5

4.32

3.94

e9/l

1.10

125

785

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

169

1141

1.50

5.80

1.8

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.87

5.73

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

280

2.01

5.69

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.03

5.63

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

159

1067

1.50

5.63

1.2

1.1

1.51

2.16

u/ml

0.68

539

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

332

1.91

5.52

1.3

1.5

12.02

12.58

umol/l

0.26

310

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

995

8624

1.19

5.46

1.9

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

116

733

1.60

5.39

3.5

3.2

0.79

0.82

nmol/l

0.38

580

(3006270) Folate [Moles/volume] in Blood

328

1.90

5.38

1.1

402.42

378.97

nmol/l

0.37

278

(3037121) Protein [Mass/volume] in Urine

210

1503

1.41

5.34

3.6

270.33

465.83

mg/l

1.90

109

729

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

101

2.68

5.32

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

149

999

1.51

5.32

1.5

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

582

4807

1.24

5.26

7.3

6.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

447

1.76

5.25

1.7

1.5

60.41

57.86

0.22

291

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

234

2.06

5.25

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

130

849

1.54

5.25

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

835

7152

1.20

5.23

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.05

5.21

2.2

2.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

262

1.99

5.20

1.6

1.5

79.52

81.42

umol/l

0.20

262

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

820

1.55

5.17

1.6

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

594

1.64

5.13

1.7

2.1

1573.33

1362.22

titre

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

154

1048

1.48

5.13

6.0

5.6

393.33

2941.03

iu/ml

0.88

157

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

164

1132

1.46

5.09

1.6

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

189

1341

1.42

5.07

1.1

1.3

74.74

169.22

titre

1.35

128

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

445

1.74

5.05

1.6

1.7

—

(3035933) Granulocytes/Leukocytes in Blood

145

979

1.49

5.03

4.3

3.3

58.10

57.67

0.16

145

979

(3011412) CD3 cells [#/volume] in Blood

439

1.74

5.00

2.1

2.5

1443.65

1125.90

e6/l

1.41

379

(3002079) Sodium [Moles/time] in 24 hour Urine

167

2.22

4.93

1.3

1.2

149.92

159.54

mmol/24h

0.30

167

(3006245) CD3-CD19+ cells/cells in Blood

187

2.15

4.89

2.2

2.5

11.03

9.15

0.45

176

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

102

641

1.60

4.89

1.1

2.69

3.30

eliau/ml

0.24

315

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

465

1.71

4.87

2.5

2.0

25.58

25.21

mg/l

0.02

172

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

209

1521

1.39

4.86

1.3

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

188

2.14

4.83

1.6

2.2

26.85

28.44

0.35

178

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

312

1.87

4.82

2.0

1.9

1.22

1.54

u/field

0.36

171

(3004451) EKG impression Narrative

215

2.05

4.81

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

536

1.65

4.78

1.4

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.67

4.74

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.61

4.72

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

546

1.64

4.71

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

516

1.66

4.69

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

518

1.65

4.62

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

511

1.65

4.60

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

519

1.65

4.59

1.5

—

(3044927) Protein electrophoresis panel - Urine

369

1.77

4.57

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

102

653

1.57

4.55

1.5

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

200

2.06

4.52

2.2

2.5

150.78

151.78

nmol/l

0.02

175

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

431

1.70

4.48

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

531

1.63

4.46

1.7

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

137

941

1.47

4.41

1.1

4.17

5.55

u/ml

0.55

504

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.69

4.41

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.06

4.39

1.7

2.9

—

(3036603) Volume of Urine

345

1.78

4.36

1.5

1.7

1820.11

1975.06

0.82

338

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

535

1.62

4.34

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

190

2.06

4.33

5.0

3.9

—

(3016038) Potassium [Moles/volume] in Urine

274

1.87

4.30

1.2

37.09

34.96

mmol/l

0.26

241

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

385

1.72

4.25

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

139

2.24

4.23

1.1

1.3

96.29

88.81

0.65

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

102

665

1.54

4.23

1.3

5.04

3.99

u/ml

0.38

312

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

642

1.55

4.20

1.1

1.51

1.52

g/l

0.16

587

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

123

836

1.48

4.20

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

123

836

1.48

4.20

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

170

1232

1.39

4.11

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

367

1.72

4.09

1.4

192949.98

81573.27

e6/l

0.45

248

(3012494) Peanut IgE Ab [Units/volume] in Serum

123

2.28

4.02

1.0

1.2

1.50

30.41

u/ml

0.52

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

238

1.90

4.00

2.6

1.9

128.75

108.41

ng/l

0.56

238

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.90

3.99

1.1

1.2

2.46

1.79

iu/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

193

1436

1.36

3.98

2.2

2.8

3.75

3.61

g/l

0.63

182

1370

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

143

2.17

3.98

1.1

97.14

92.12

0.37

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

137

962

1.43

3.97

1.7

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

5.56

3.97

1.1

8.81

8.52

mmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.48

3.95

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

410

1.67

3.91

3.4

5.7

72.25

84.77

u/ml

0.09

135

(3042631) Mycobacterium sp identified in Specimen

550

1.57

3.91

3.2

2.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

180

1330

1.37

3.89

2.2

2.7

187.02

194.03

0.45

170

1272

(44790049) Parainfluenza type 3 nucleic acid detection

575

1.56

3.87

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

575

1.56

3.87

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

575

1.56

3.87

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

575

1.56

3.87

1.8

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

492

4128

1.21

3.85

1.6

1.5

—

(3001729) Color of Synovial fluid

3.95

3.79

1.1

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

588

1.54

3.74

5.9

6.5

11.24

11.86

mg/l

0.63

551

(4146454) Self-monitoring of blood glucose

362

1.69

3.74

2.8

2.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

102

685

1.50

3.73

1.3

7.64

3.98

u/ml

0.67

242

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.91

3.73

1.3

1.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

370

1.68

3.72

1.1

278.79

287.67

mg/l

0.49

342

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

208

1583

1.33

3.71

1.6

1.5

1.93

6.44

iu/ml

0.48

302

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.51

3.70

1.0

1.2

0.57

5.20

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

677

5876

1.17

3.62

2.0

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

1.95

3.61

2.2

4.2

78.96

63.32

mg/l

0.76

142

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.67

3.59

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

299

1.75

3.58

1.9

2.0

6.74

6.43

mmol/l

0.49

221

(3033099) Centromere Ab [Titer] in Serum

2.40

3.55

1.0

1.1

—

(4195642) Thrombophilia screening test

604

1.52

3.54

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

376

1.66

3.53

1.1

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

221

1.86

3.49

2.3

27.02

53.62

umol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

265

1.78

3.47

1.4

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.47

3.45

1.2

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

310

1.72

3.45

2.2

2.9

250.00

209.22

e6/l

0.63

258

(3008401) Mugwort IgE Ab [Units/volume] in Serum

128

914

1.41

3.43

1.1

1.09

1.05

u/ml

0.03

390

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

334

1.68

3.40

1.1

20.61

16.53

u/ml

0.37

145

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

373

1.64

3.38

1.1

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.44

3.37

1.2

1.4

7.40

6.42

u/ml

0.04

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

140

2.08

3.36

1.4

1.6

12.26

15.95

pmol/l

2.03

115

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

397

1.62

3.35

3.8

3.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

129

933

1.39

3.24

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

520

1.53

3.23

1.9

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

409

1.60

3.23

1.7

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

152

1130

1.35

3.22

1.4

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

194

1495

1.31

3.22

2.3

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

116

2.16

3.21

1.9

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.17

3.19

2.1

1.9

34.80

48.13

umol/l

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

6.37

3.18

1.3

4.2

40.43

25.33

umol/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.80

3.18

1.1

1.85

1.45

umol/24h

0.29

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

334

1.65

3.15

1.2

1.3

162.64

175.62

pmol/l

0.34

334

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

158

1.97

3.13

1.7

1.9

129.55

186.88

2.84

152

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

172

1.92

3.13

2.2

2.9

0.62

0.60

mmol/l

0.82

172

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

259

1.74

3.13

1.4

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.41

3.13

1.0

1.2

3.01

4.48

u/ml

0.15

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.63

3.13

1.1

1.0

90.33

78.64

ug/l

0.52

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

508

1.52

3.12

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

305

1.68

3.10

2.0

2.7

762.78

467.02

e6/l

0.89

242

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

431

3652

1.20

3.08

2.9

2.8

66.84

68.53

ml/min/173m2

0.40

224

1515

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.80

3.08

1.1

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

109

773

1.42

3.08

1.2

24.64

37.39

u/l

1.06

670

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1073

9731

1.13

3.07

3.2

0.75

0.79

ug/l

0.54

676

6275

(3052592) Norovirus Ag [Presence] in Stool

2.44

3.04

1.2

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

611

1.46

3.00

1.1

1.2

125.28

114.52

2.28

559

(3010726) Horse dander IgE Ab [Units/volume] in Serum

122

887

1.38

3.00

1.1

2.84

1.65

u/ml

0.72

442

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

182

1.87

2.99

1.5

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

182

1.87

2.99

1.5

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

1.89

2.99

2.7

2.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.40

2.96

1.2

1.0

6.81

7.82

mg/g

0.29

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.54

2.95

1.6

1.9

54.43

36.76

pmol/l

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

207

1631

1.28

2.93

2.4

2.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

365

1.60

2.91

1.1

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

169

1298

1.31

2.91

1.7

2.3

0.00

g/l

0.50

138

1146

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.32

2.90

1.3

1.4

1.18

1.16

mmol/l

0.73

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

358

1.60

2.89

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.70

2.88

1.3

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

470

1.52

2.87

1.2

64.89

65.30

u/l

0.02

415

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.39

2.87

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

277

2268

1.23

2.83

4.3

3.2

1.02

ratio

1.08

254

2051

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

179

1.85

2.81

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

137

1.98

2.79

1.3

103.00

107.50

0.21

125

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1246

11457

1.11

2.78

2.3

2.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

292

1.65

2.77

1.6

1.5

25.80

25.85

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.08

2.76

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

158

1212

1.31

2.76

1.8

2.3

0.00

g/l

-0.00

138

1144

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1359

0.72

2.76

1.3

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.17

2.76

1.2

—

(3017704) Immunofixation for Urine

217

1.76

2.75

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.71

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

650

1.42

2.70

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.60

2.70

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

219

1.74

2.67

2.2

1.5

0.49

0.50

e9/l

0.06

219

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.75

2.67

1.2

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

352

1.57

2.61

1.1

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

184

1.80

2.60

2.2

2.1

32.61

31.13

0.18

184

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

234

2862

0.81

2.59

1.5

1.6

940.43

1015.59

mu/l

0.76

202

2438

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

149

1.88

2.55

1.3

0.32

0.29

g/l

0.58

120

(3028679) Herpes simplex virus Ab [Presence] in Serum

284

1.62

2.53

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.27

2.50

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.27

2.50

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.27

2.50

1.2

—

(3000012) Reticulocyte production index

652

1.40

2.49

1.6

2.2

0.96

0.87

0.58

453

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

486

1.47

2.49

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

429

1.50

2.48

2.0

2.4

42.51

38.89

1.26

424

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

181

1436

1.27

2.48

2.0

2.4

96.89

91.63

2.86

171

1388

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

217

1.71

2.47

1.9

1.7

—

(4268621) Lupus anticoagulant assay

495

1.46

2.47

2.6

2.3

—

(3000060) B lymphocytes [#/volume] in Blood

144

1.88

2.45

2.0

2.3

0.21

0.33

e9/l

0.34

(3028433) Virus identified in Specimen by Culture

144

1.88

2.45

1.3

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.67

2.45

1.1

0.27

3.67

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

106

783

1.36

2.43

1.1

2.90

3.97

u/ml

0.32

389

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

400

1.51

2.40

3.6

3.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

329

1.56

2.37

1.0

1.1

15.13

2.64

u/ml

0.44

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

154

1952

0.78

2.36

1.1

0.58

0.61

ratio

0.39

223

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.64

2.36

1.6

1.4

21.70

31.35

nmol/l

—

(3007463) Buprenorphine [Presence] in Urine

4.12

2.36

17.1

6.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.82

2.34

1.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.12

2.28

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

640

1.38

2.24

1.7

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

216

1.67

2.24

1.8

1.9

2.38

2.97

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.10

2.22

1.3

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

179

1.74

2.22

1.7

1.4

4.33

4.57

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

5.56

2.21

1.2

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1077

0.72

2.21

1.4

1.6

54.98

60.42

ug/l

0.74

1077

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

351

1.51

2.21

2.2

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

109

826

1.33

2.15

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.78

2.13

1.1

0.01

0.04

u/ml

—

(3014271) Vancomycin [Susceptibility]

159

1.76

2.13

3.6

2.8

—

(3016750) Collection duration of Urine

220

1.64

2.11

2.6

2.2

529.00

490.95

min

1.53

169

(3016650) Hepatitis A virus Ab [Presence] in Serum

108

822

1.32

2.08

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

300

1.54

2.07

1.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.00

2.07

2.0

1.2

33.80

42.90

umol/24h

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.00

2.07

1.2

2.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.71

2.06

1.1

70.40

101.19

titre

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.18

2.04

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

192

1.67

2.02

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.82

2.00

4.4

5.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

715

1.33

1.99

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

2.57

1.94

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

373

0.56

1.93

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

738

1.32

1.90

1.1

4.05

4.89

u/ml

0.25

324

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.92

1.90

2.2

2.6

103.37

337.71

ug/l

0.36

(3025130) Human papilloma virus identified in Specimen

739

1.32

1.89

1.6

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

119

933

1.28

1.87

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.98

1.84

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.53

1.83

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

101

1.88

1.80

1.8

1.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.92

1.79

1.1

1.2

72.00

76.19

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.00

1.79

1.4

1.2

0.81

183.14

mg/l

1.26

(3003740) Influenza virus B Ag [Presence] in Specimen

118

933

1.27

1.76

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

139

1.73

1.75

1.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.34

1.74

1.2

1.1

—

(4038314) Semen analysis, post vasectomy

2.67

1.72

1.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

3.85

1.71

1.2

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1220

0.77

1.71

1.7

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

1.69

1.0

1.1

—

(4015189) Microbial culture of sputum

2.00

1.69

1.5

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

119

1.77

1.65

1.1

1.2

—

4.57

—

(3028717) Thiamine [Mass/volume] in Blood

2.10

1.65

1.2

1.3

56.85

64.63

ug/l

0.96

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.80

1.65

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.38

1.61

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.07

1.59

1.7

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

543

4928

1.11

1.58

5.4

4.5

31.18

32.57

2.42

410

3223

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

363

1.41

1.56

1.8

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.11

1.54

2.1

2.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

107

1.78

1.54

1.4

2.9

113.46

98.81

ng/l

0.20

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.37

1.45

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.12

1.44

1.5

2.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.73

1.43

1.2

1.0

0.08

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

674

1.28

1.43

1.1

0.20

0.45

u/ml

0.59

204

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

125

1.68

1.43

1.1

—

(3004775) Volume in Urine collected for unspecified duration

320

1.41

2.8

2.3

647.65

626.48

0.16

211

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

237

1.48

1.41

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

181

1.55

1.39

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.42

1.39

1.9

2.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.08

1.38

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

322

1.40

1.37

1.0

1.1

4.77

3.56

u/ml

0.11

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.61

1.36

1.3

1.5

17.52

14.88

pmol/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

698

0.74

1.35

2.8

3.9

22.62

28.16

u/ml

0.50

675

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

366

1.37

1.34

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

366

1.37

1.34

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

366

1.37

1.34

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

1.30

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.84

1.29

1.1

—

(44806420) Estimation of glomerular filtration rate

490

1.31

1.29

2.3

2.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

173

1478

1.18

1.29

1.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.09

1.27

1.4

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

280

0.61

1.26

8.9

6.9

33.83

11517.64

u/ml

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

244

1.44

1.25

1.1

1.2

1.05

1.06

ratio

0.50

196

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

208

1809

1.16

1.24

1.5

1.3

209.74

222.87

miu/ml

0.19

860

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

243

2137

1.14

1.24

2.6

3.6

57.56

63.87

u/ml

0.11

235

2070

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.40

1.24

1.5

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.86

1.23

24.9

11.4

5.01

5.77

mmol/l

0.67

(3003694) ABO and Rh group [Type] in Blood

1537

14713

1.06

1.23

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.91

1.22

2.1

1.9

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.63

1.21

1.4

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.16

1.21

1.0

—

(4034850) Laboratory test

160

1367

1.18

1.21

9.2

8.6

—

(3051611) Lipemic interference index of Serum or Plasma

409

1.32

1.19

2.2

3.2

13.97

12.94

index

0.30

240

(3050129) First trimester maternal screen panel - Serum or Plasma

159

1852

0.85

1.18

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

265

1.40

1.16

1.4

1.6

11.13

6.53

u/l

0.79

220

(3043238) Trisomy 21 risk [Likelihood] in Fetus

108

1298

0.83

1.16

1.5

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

270

2408

1.13

1.7

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

216

1.44

1.13

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.33

1.12

1.0

5.57

18.13

u/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

167

1.50

1.12

1.0

1.1

97.26

90.69

0.52

135

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

143

1.54

1.11

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.26

1.10

1.1

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.0

—

(3024316) Viscosity of Plasma

2.38

1.09

1.0

1.7

—

1.83

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.82

1.08

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

128

1.56

1.08

1.3

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

105

1.62

1.05

1.4

1.3

0.40

0.35

mmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

105

1.62

1.05

1.0

31.88

35.40

iu/ml

0.06

105

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

211

1.42

1.05

1.1

254.49

203.27

iu/ml

0.33

211

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.27

1.03

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.89

1.01

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

155

1345

1.16

1.00

1.4

1.3

—

(40757373) Influenza virus identified in Isolate

1.77

1.00

2.8

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

773

1.21

1.00

1.4

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

511

1.26

0.99

1.5

1.4

82823.39

52762.53

e6/l

0.23

282

(3042733) HLA Ab [Presence] in Serum

164

1.47

0.99

5.2

4.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.17

0.98

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

2.17

0.98

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

283

1.35

0.98

1.2

19.55

26.32

u/l

0.46

239

(3005033) Fetal Nuchal fold Thickness US

106

1251

0.84

0.97

1.5

1.27

0.03

909

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.95

0.97

2.4

2.1

0.43

0.64

u/field

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

129

1496

0.86

0.96

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

453

1.26

0.93

1.8

2.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

287

1.33

0.91

1.0

1.1

0.79

4.10

u/ml

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

287

1.33

0.91

1.2

79.90

93.36

u/l

0.45

244

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

142

1623

0.87

0.88

1.5

58.44

60.74

ug/l

0.20

121

1372

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

127

1.50

0.88

1.6

10.17

8.18

ug/l

1.30

127

(3023199) Leukocytes [#/volume] in Pleural fluid

575

1.22

0.87

1.5

2499.70

3926.55

e6/l

0.39

394

(3050794) Legionella sp Ab [Presence] in Serum

1.86

0.87

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

370

1.27

0.85

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.76

0.83

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

154

1.43

0.83

1.8

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.69

0.82

1.1

1.2

127.38

147.51

ng/l

—

(3009871) Measles virus Ab [Titer] in Serum

180

1.39

0.81

1.6

1.7

5648.00

2820.00

titre

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

337

1.28

0.81

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

268

1.31

0.79

1.1

1619.92

1472.46

miu/ml

0.37

268

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.77

0.76

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.57

0.74

4.5

6.7

10.68

10.48

0.10

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.57

0.74

1.3

1.4

—

3764.44

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.61

0.72

1.8

2.4

72.46

95.20

pmol/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

142

1.41

0.72

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

135

1519

0.89

0.70

1.4

1.5

1.13

1.23

ratio

0.72

921

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

135

1519

0.89

0.70

1.4

1.5

0.91

0.96

ratio

0.73

912

(3036670) Protein [Mass/volume] in Synovial fluid

109

1.47

0.70

1.4

1.3

36.88

38.39

g/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.92

0.70

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.92

0.70

1.6

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

112

1275

0.88

0.70

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

135

1517

0.89

0.69

1.4

1.5

1.10

1.18

ratio

0.47

910

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

265

1.28

0.69

4.9

7.6

27.50

95.40

ug/l

0.54

176

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

239

1.30

0.69

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

117

0.60

0.67

1.0

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.79

0.66

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.79

0.66

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

111

1.44

0.65

22.3

6.8

5.26

5.21

kpa

0.06

111

(3036782) Glucose [Moles/volume] in Pleural fluid

486

1.20

0.64

1.3

1.4

6.05

6.25

mmol/l

0.20

456

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

181

1.33

0.63

1.1

1.2

—

(3014891) Appearance of Pleural fluid

1.59

0.61

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

703

1.15

0.60

2.1

2.3

4.50

7.49

umol/l

2.15

524

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

278

0.75

0.60

1.5

801.64

482.43

pmol/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.60

0.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

317

1.23

0.59

1.3

1.5

34.75

38.59

nmol/l

0.28

285

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.53

0.59

1.3

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

237

1.27

0.58

1.6

1.5

—

(3019174) dRVVT (LA screen)

1.67

0.56

1.0

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

141

1.35

0.56

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.51

0.56

1.1

1.7

—

(40768441) Liver Pathology biopsy report

374

0.80

0.55

1.3

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.50

0.54

1.0

1.1

—

(40768793) Breast Pathology biopsy report

111

999

1.11

0.51

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

233

1.25

0.50

1.3

1.2

11.34

9.74

mm/h

0.31

233

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.50

1.4

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

153

1.31

0.50

1.1

1.0

6.97

11.74

u/ml

0.38

108

(3036071) Salmonella sp Ab [Titer] in Serum

162

1.30

0.50

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

225

1.25

0.49

1.6

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

588

1.14

0.47

1.1

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

218

1.24

0.46

1.8

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

218

1.24

0.46

1.8

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

218

1.24

0.46

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

218

1.24

0.46

1.8

2.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

209

1.25

0.46

29.5

27.0

109.58

116.06

ug/l

0.24

176

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

467

1.16

0.46

1.1

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

194

1804

1.08

0.46

1.5

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

618

1.13

0.45

2.2

2.5

58.28

23.82

iu/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

822

0.89

0.45

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.61

0.43

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.1

0.01

0.36

u/ml

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

622

1.13

0.42

2.0

19.15

25.40

ug/l

0.66

610

(3041672) Baker's yeast Ab [Presence] in Serum

1.56

0.42

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.56

0.42

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

1.20

0.41

1.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

416

1.16

0.41

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.52

0.41

1.0

1.3

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.52

0.41

1.8

3.0

2.33

3.02

mg/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.36

0.41

1.4

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

325

0.83

0.40

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.31

0.39

1.4

1.1

—

(3045788) Cell count panel - Pleural fluid

475

1.14

0.39

1.7

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

495

1.13

0.38

1.2

1.1

2.42

3.20

iu/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

666

1.11

0.37

1.5

30.53

32.98

g/l

0.99

609

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

152

1.25

0.37

1.1

3.73

6.00

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

235

0.81

0.36

1.1

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

100

916

1.09

0.36

1.7

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

493

4754

1.04

0.36

3.5

4.7

25.23

32.21

ug/l

0.15

409

3890

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

621

1.11

0.35

4.5

2.6

13.31

13.12

1.02

614

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

122

0.74

0.35

1.0

1.1

—

(4035726) Immunohistochemistry procedure

412

3965

1.04

0.34

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

155

0.77

0.33

3.3

3.1

—

(3024932) HLA-DR beta [Type]

155

1.23

0.32

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

411

0.88

0.31

1.3

1.7

7.59

7.71

mmol/l

0.13

394

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.71

0.30

1.0

1.3

67.43

68.11

ug/l

—

(3024471) HLA-A [Type]

157

1.21

0.29

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

1.20

0.28

2.0

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

1.20

0.28

2.0

2.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.23

0.27

1.3

2.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

168

1.19

0.27

3.7

2.7

19.80

110.15

au/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

159

1.20

0.26

2.1

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

436

0.89

0.26

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

329

1.13

0.25

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

184

1754

1.05

0.25

3.2

3.9

155.78

1667.67

u/ml

1.49

159

1510

(3045462) Protein/Creatinine [Ratio] in Urine

1.25

0.25

4.0

5.9

27.36

69.14

mg/mmol

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

123

1.22

0.25

1.1

1.3

9.50

13.70

pmol/l

—

(3045142) Bone marrow Pathology biopsy report

528

0.91

0.24

1.1

1.4

—

(40768795) Lymph node Pathology biopsy report

465

0.90

0.24

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

236

1.14

0.24

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

233

0.86

0.23

1.1

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

125

0.80

0.23

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

125

0.80

0.23

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

125

0.80

0.23

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

125

0.80

0.23

1.1

—

(3002619) Bacteria identified in Specimen by Culture

105

0.76

0.21

1.3

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.25

0.20

1.4

1.2

457.20

262.73

pmol/l

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.73

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.22

0.20

2.2

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.20

0.19

4.0

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.20

0.19

1.3

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

142

0.84

0.17

1.2

1.3

41.68

379.02

ug/l

—

(21494434) Karyotype in Bone marrow

413

0.92

0.17

1.3

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.75

0.17

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.75

0.17

25.0

8.3

0.22

0.19

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

439

1.07

0.15

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

792

1.05

0.14

1.4

2.81

3.94

ug/l

1.59

713

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

212

0.90

0.14

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

549

1.06

0.13

1.3

—

(3047189) Immunofixation for 24 hour Urine

209

1.10

0.13

1.2

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

347

1.07

0.11

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

299

1.07

0.10

3.0

2.8

41.63

40.03

0.22

154

(44786800) Granulocytes/Leukocytes in Body fluid

1.06

0.09

1.0

1.4

21.00

28.61

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

233

1.07

0.09

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

233

1.07

0.09

1.2

1.6

—

(3006462) Nitrate [Presence] in Urine

194

1.08

0.09

4.9

3.1

—

(3006598) pH of Arterial cord blood

1.07

0.08

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

518

1.04

0.08

1.6

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.03

0.08

1.0

1.1

16.47

7.86

u/ml

—

(40768806) Pleura Pathology biopsy report

501

0.96

0.08

1.5

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.14

0.08

1.2

2.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1.08

0.07

1.4

1.7

38.49

40.02

g/l

0.48

166

(3051101) Glucose [Moles/volume] in Cord blood

1.08

0.07

8.3

7.0

8.92

8.20

mmol/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.03

0.07

1.1

1.3

—

147.58

—

(3020650) Glucose [Presence] in Urine

157

1.08

0.07

1.6

1.5

0.00

estimate

-0.00

157

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

375

1.04

0.05

1.3

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

326

1.04

0.05

4.7

2.4

19.30

32.29

mg/l

2.01

239

(40765089) Chromosome analysis panel - Blood by G-banded

170

0.94

0.04

1.0

—

(3044007) Cell count panel - Peritoneal fluid

170

0.94

0.04

2.4

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

170

1.06

0.04

1.6

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

101

998

1.01

0.02

3.1

4.0

139.51

1040.86

u/ml

2.10

904

(40768800) Prostate Pathology biopsy report

112

1110

1.01

0.01

1.3

1.2

—

(4133840) Spirometry

134

1.04

0.00

1.1

1.2

—

(4211845) Urine protein measurement

214

1.03

0.00

4.7

3.0

—

(4281824) Cell count and differential, peritoneal fluid

474

1.01

0.00

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

162

0.99

0.00

1.0

1.1

—

(3034426) Prothrombin time (PT)

143

0.98

0.00

1.0

1.2

27.57

29.14

0.88

143

(3035880) pH of Pleural fluid

261

1.00

0.00

1.1

1.3

7.33

7.39

0.36

172

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

5.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

76.63

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.01

-0.00

1.1

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

19.90

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

0.02

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.02

-0.00

1.0

1.2

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.44

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2530.71

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.00

-0.00

1.0

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.0

—

5.60

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.3

—

35.31

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_SLEEPDISOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_SLEEPDISOTH	1.334 [1.19, 1.49]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.532

During the follow-up period (1.1.1998 — 31.12.2019), 1071 out of 9820 females with G6_SLEEPDISOTH died.

Males

Parameter	HR [95% CI]	p-value
G6_SLEEPDISOTH	1.354 [1.24, 1.48]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2424 out of 14274 males with G6_SLEEPDISOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_SLEEPDISOTH.

N-year risk	Females	Males
1	0.118%	0.226%
5	0.882%	1.469%
10	2.276%	3.58%
15	4.204%	6.951%
20	7.155%	11.548%

Relationships between endpoints

↥

Index endpoint: G6_SLEEPDISOTH – Other sleep disorders

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other sleep disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints